FTK Flotek Industries Inc

---

---

---

---

---

---

---

---

General

Flotek creates unique solutions to reduce the environmental impact of energy on air, water, land and people. A technology-driven, specialty green chemistry and data company, Flotek helps customers across industrial and commercial markets improve their environmental performance. The Company serves specialty chemistry needs for both domestic and international energy markets.

The Company’s Chemistry Technologies (“CT”) segment designs, develops, manufactures, packages and distributes green specialty chemicals that help customers improve their return on invested capital, lower operational costs and realize tangible environmental benefits aimed at enhancing the profitability of hydrocarbon producers.

The Company’s Data Analytics (“DA”) segment aims to enable users to maximize the value of their hydrocarbon associated processes by providing analytics associated with their hydrocarbon streams in seconds rather than minutes or days. The real-time access to information prevents waste, reduces reprocessing and allows users to pursue automation of their hydrocarbon streams to maximize their profitability.

The Company’s two operating segments, CT and DA, are supported by its Research & Innovation advanced laboratory capabilities. For further discussion of our operations and segments, see Note 17, “Business Segment, Geographic and Major Customer Information.”

As used herein, “Flotek,” the “Company,” “we,” “our” and “us” refers to Flotek Industries, Inc. and/or the Company’s wholly-owned subsidiaries. The use of these terms is not intended to connote any particular corporate status or relationship.

Sources and Uses of Liquidity

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

The Company currently funds its operations with cash on hand, availability under the ABL (see Note 9, “Debt and Convertible Notes Payable”) and other liquid assets. The Company recognized $8.8 million and $1.6 million of gross profit and net income, respectively, during the three months ended March 31, 2024. While we believe that our cash, liquid assets, and availability under the ABL will provide us with sufficient financial resources to fund operations to meet our capital requirements and anticipated obligations as they become due, uncertainty surrounding the long-term stability and strength of the oil and gas markets could have a negative impact on our liquidity. The availability of capital is dependent on the Company’s operating cash flow, which is currently expected to be principally derived from the ProFrac Agreement (see Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions”). Related party revenues for the three months ended March 31, 2024 included Contract Shortfall Fees of $8.7 million. Related party receivables as of March 31, 2024 included accrued Contract Shortfall Fees of $13.7 million comprised of the remaining 2023 Contract Shortfall Fees payment of $5.0 million, which was collected in April 2024, and $8.7 million of accrued 2024 Contract Shortfall Fees, which will be due in the first quarter of 2025 under the terms of the ProFrac Agreement.

Based upon our outlook for future cash flows from operations, which includes the collection of the Contract Shortfall Fees, combined with cash on hand and availability under the ABL, the Company believes it has sufficient financial resources to fund operations and meet its capital requirements and anticipated obligations as they become due in the next twelve months. While the Company cannot guarantee a sufficient level of cash flows in the future, the unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements reflect all adjustments, in the opinion of management, necessary for the fair statement of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The financial statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the SEC regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim financial statements should be read in conjunction with

---

the audited consolidated financial statements and notes included in the Company’s 2023 Annual Report. A copy of the 2023 Annual Report is available on the SEC’s website, www.sec.gov or on the Company’s website, www.flotekind.com. The information contained on the SEC’s website and the Company’s website does not form a part of this Quarterly Report.

All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries.

Cash Equivalents

Cash equivalents consist of highly liquid investments with maturities of three months or less at the date of purchase.

Restricted Cash

The Company’s restricted cash was $0.1 million and $0.1 million as of March 31, 2024 and December 31, 2023, respectively. The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain in accordance with the terms of its credit card program with a financial institution.

Accounts Receivable and Allowance for Credit Losses

Accounts receivable and accounts receivable, related party, arise from product sales and services and are stated at estimated net realizable value. This value incorporates an allowance for credit losses to reflect any loss anticipated on accounts receivable balances. The Company applies the current expected credit loss (CECL) model, which requires immediate recognition of expected credit losses over the contractual life of receivables and records the appropriate allowance for credit losses as a charge to Operating Cost and Expenses. The allowance for credit losses is based on a combination of the individual customer circumstances, credit conditions, and historical write-offs and collections. The Company writes off specific accounts receivable when they are determined to be uncollectible. The recovery of accounts receivable previously written off is recorded as a reduction to the allowance for credit losses charged to operating expense.

The majority of the Company’s customers are engaged in the energy industry. The cyclical nature of the energy industry may affect customers’ operating performance and cash flows, which directly impact the Company’s ability to collect on outstanding obligations. Additionally, certain customers are located in international areas that are inherently subject to risks of economic, political, and civil instability, which can impact the collectability of receivables.

Changes in the allowance for credit losses are as follows (in thousands):

			March 31, 2024						December 31, 2023
Balance, beginning of year			$	745					$	623
Charges to provision for credit losses, net of recoveries			32						138
Write-offs			(405)						(16)
Balance, end of period			$	372					$	745

As of March 31, 2024 and December 31, 2023 the Company had not recorded an allowance for credit losses for the related party accounts receivable, including ProFrac Services, LLC (see Note 16, “Related Party Transactions”).

Contract Assets

The Company’s contract assets represent consideration issued in the form of convertible notes (Contract Consideration Convertible Notes Payable as discussed in Note 9, “Debt and Convertible Notes Payable”) and other incremental costs related to obtaining the ProFrac Agreement (see Note 16, “Related Party Transactions”). The contract assets are amortized over the term of the ProFrac Agreement (originally 10 years) based on forecasted revenues as goods are transferred to ProFrac Services, LLC, and the amortization is presented as a reduction of the transaction price included in related party revenue in the consolidated statements of operations.

The contract assets are tested for recoverability on a recurring basis and the Company will recognize an impairment loss to the extent that the carrying amount of the contract assets exceeds the amount of consideration the Company expects to receive in the future for the transfer of goods under the ProFrac Agreement less the direct costs that relate to providing those goods in the future.

---

Inventories

Inventories consist of raw materials and finished goods and are stated at the lower of cost determined by using the weighted-average cost method, or net realizable value. Finished goods inventories include raw materials, direct labor and production overhead. The Company periodically reviews inventories on hand and current market conditions to determine if the cost of raw materials and finished goods inventories exceed current market prices and impairs the cost basis of the inventory accordingly. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its net realizable value if those amounts are determined to be less than cost. Write-downs or write-offs of inventory are charged to cost of sales.

Property and Equipment

Property and equipment are stated at cost. Plant and equipment under finance leases are stated at the present value of the lease payments. The Company capitalizes costs associated with the acquisition of major software for internal use. The cost of ordinary maintenance and repair is charged to operating expense, while replacement of critical components and major improvements are capitalized. Depreciation or amortization of property and equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows:

Buildings and leasehold improvements			2-30 years
Machinery and equipment			7-10 years
Furniture and fixtures			3 years
Land improvements			20 years
Transportation equipment			2-5 years
Computer equipment and software			3-7 years

Property and equipment, including ROU assets, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. If events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable, the Company first compares the carrying amount of an asset or asset group to the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset. If the carrying amount of an asset or asset group exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset, the Company will determine the fair value of the asset or asset group. The amount of impairment loss recognized is the excess of the asset or asset group’s carrying amount over its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary.

Assets to be disposed of are reported as assets held for sale at the lower of the carrying amount or the asset’s fair value less cost to sell and depreciation is ceased. Upon sale or other disposition of an asset, the Company recognizes a gain or loss on disposal measured as the difference between the net carrying amount of the asset and the net proceeds received.

Leases

The Company leases certain facilities, land, vehicles, and equipment. The Company determines if an arrangement is classified as a lease at inception of the arrangement. The Company recognizes a ROU asset and a lease liability at the lease commencement date.

ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the related lease. Finance leases are under the current and non-current liabilities and the underlying assets are included in property and equipment on the consolidated balance sheet. For operating and finance leases, the lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method.

As most of the Company’s leases do not provide an implicit rate of return, on a quarterly basis, the Company’s incremental borrowing rate is used, together with the lease term information available at commencement date of the lease, in determining the present value of lease payments. Operating lease liabilities include the noncancellable period of the lease plus related options to extend or terminate lease terms that are reasonably certain of being exercised. Lease payments included in the measurement of the lease liability comprise fixed payments owed over the lease term.

Leases with an initial term of 12 months or less (“short term leases”) are not recorded on the balance sheet; and the lease expense on short-term leases is recognized on a straight-line basis over the lease term.

---

The Company entered into a sublease for its former headquarters, which is being accounted for under lessor accounting. The nature of the sublease did not relieve the Company of its obligations under the original lease. The lease for the prior headquarters was an operating lease and, as such, the Company continues to account for the original lease as it did prior to entering the sublease. Since the former facility is not a component of the Company’s central operations, the income from the sublease and the expenses under the original lease are recorded in Other income, net on our Consolidated Statement of Operations.

Convertible Notes Payable and Liability Classified Contract Consideration Convertible Notes Payable

The Company accounted for the Convertible Notes Payable at amortized cost pursuant to Financial Accounting Standards Board (“FASB”) ASC Topic 470, Debt.

The Company accounted for the Contract Consideration Convertible Notes Payable issued as consideration related to a related party contract (see Note 9, “Debt and Convertible Notes Payable”), as liability classified convertible instruments in accordance with FASB ASC 718, “Stock Compensation” (“ASC 718”). Under ASC 718, liability classified convertible instruments are measured at fair value at the grant date and at each reporting date (see Note 10, “Fair Value Measurements”) with the change in fair value included in the consolidated statements of operations.

The Convertible Notes Payable and Contract Consideration Convertible Notes Payable were converted during 2023 through a series of transactions into the Company’s common stock. See Note 13, “Stockholders’ Equity” for additional information.

Fair Value Measurements

The Company categorizes financial assets and liabilities using a three-tier fair value hierarchy, based on the nature of the inputs used to determine fair value. Inputs refer broadly to assumptions that market participants would use to value an asset or liability and may be observable or unobservable. When determining the fair value of assets and liabilities, the Company uses the most reliable measurement available. See Note 10, “Fair Value Measurements.”

Revenue Recognition

The Company recognizes revenue when it satisfies performance obligations under the terms of the contract with a customer, and control of the promised goods are transferred to the customer or services are performed, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services.

The Company recognizes revenue based on a five-step model when all of the following criteria have been met: (i) a contract with a customer exists, (ii) performance obligations have been identified, (iii) the price to the customer has been determined, (iv) the price to the customer has been allocated to the performance obligations, and (v) performance obligations are satisfied.

Products and services are sold with fixed or determinable prices. Variable consideration is estimated for the Contract Shortfall Fees from the ProFrac Agreement (see Note 16, “Related Party Transactions”) using the most likely amount and the Company includes an estimated amount of variable consideration in the transaction price only if it is probable that a subsequent change in the estimate of the amount of variable consideration would not result in a significant revenue reversal. A significant revenue reversal would occur if a subsequent change in the estimate of the variable consideration would result in a significant downward adjustment to the amount of cumulative revenue recognized from that contract when the change in estimate occurs. Certain sales include right of return provisions, which are considered when recognizing revenue and deferred accordingly, and discounts are offered to customers for prompt payment. The Company does not act as an agent in any of its revenue arrangements.

In recognizing revenue for products and services, the Company determines the transaction price of contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services can be distinguished in the context of the contract. The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable included in accounts receivable, net and accounts receivable, related party on our Consolidated Balance Sheet.

The majority of the CT segment revenue is chemical products that are sold at a point in time based on when control transfers to the customer determined by agreed upon delivery terms. Contracts with customers for the sale of products generally state the terms of the sale, including the quantity and price of each product purchased. Additionally, the CT segment offers various services associated to products sold, which includes field services, installation, maintenance, and other functions. These services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation when the Company has a right to invoice the customer.

---

The DA segment recognizes revenue for sales of equipment at the time of sale based on when control transfers to the customer based on agreed upon delivery terms. Additionally, the Company offers various services associated with products sold, which includes field services, installation, maintenance, and other functions. Services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation. There may be additional performance obligations related to providing ongoing or reoccurring maintenance. Revenue for these types of arrangements is recognized ratably over time throughout the contract period. Additionally, the Company may provide subscription-type arrangements with customers in which monthly reoccurring revenue is recognized ratably over time in accordance with agreed upon terms and conditions. Customers may be invoiced for such maintenance and subscription-type arrangements, and revenue not yet recognizable is reported under accrued liabilities and deferred revenue on the consolidated balance sheets.

Payment terms for both the CT and DA segments are customarily 30-60 days for domestic products or services and 60-90 days for international products and services from invoice receipt. Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Contract assets associated with incomplete performance obligations are not material.

The Company applies several practical expedients including:

•Sales commissions are expensed as selling, general and administrative expenses when incurred because the amortization period is generally one year or less.

•The Company’s payment terms are short-term in nature with settlements of one year or less. As a result, the Company does not adjust the promised amount of consideration for the effects of a significant financing component.

•In most service contracts, the Company has the right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company’s performance obligations completed to date and as such the Company recognizes revenue in the amount to which it has a right to invoice.

•The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. Such taxes are included in accrued liabilities on our consolidated balance sheet until remitted to the governmental agency.

Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of sales in our consolidated statement of operations.

Foreign Currency Translation

The Company’s functional currency is primarily the U.S. dollar. The Company operates principally in the United States and substantially all assets and liabilities of the Company are denominated in U.S. dollars. Financial statements of foreign subsidiaries that are not U.S. dollar functional currency are prepared using the currency of the primary economic environment of the foreign subsidiaries as the functional currency. Assets and liabilities of those foreign subsidiaries are translated into U.S. dollars at exchange rates in effect as of the end of identified reporting periods. Revenue and expense transactions are translated using the average monthly exchange rate for the reporting period. Resultant translation adjustments are recognized as other comprehensive income (loss) within stockholders’ equity.

Comprehensive Income

Comprehensive income encompasses all changes in stockholders’ equity, except those arising from investments and distributions to stockholders. The Company’s comprehensive income loss includes consolidated net income (loss) and foreign currency translation adjustments.

Research and Development Costs

Expenditures for research activities relating to product development and improvement are charged to expense as incurred.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for temporary differences between financial statement carrying amounts and the tax bases of assets and liabilities and are measured using the tax rates expected to be in effect when the differences reverse. Deferred tax assets are also recognized for operating loss and tax credit carry forwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date.

---

A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets.

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

The Company’s policy is to record interest and penalties related to uncertain tax positions as income tax expense.

Stock-Based Compensation

Stock-based compensation expense, related to stock options, restricted stock awards and restricted stock units, is recognized based on their grant-date fair values. The Company recognizes compensation expense, net of estimated forfeitures, on a straight-line basis over the requisite service period of the award. Estimated forfeitures are based on historical experience.

Stock Warrants

The Company evaluated the Pre-Funded Warrants issued in February 2023 (the “February 2023 Warrants”) (see Note 13, “Stockholders’ Equity) in accordance with ASC 815-40, “Contracts in Entity’s Own Equity” and determined the February 2023 Warrants meet the criteria to be classified within stockholders’ equity. Accordingly, the Company reclassified the balance of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”) upon conversion for the February 2023 Warrants within additional paid in capital.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates.

Significant items subject to estimates and assumptions include estimated variable consideration included in contract transaction price; the useful lives of property and equipment; long lived asset impairment assessments; stock-based compensation expense; allowance for credit losses for accounts receivable; valuation allowances for inventories and deferred tax assets; recoverability and timing of the realization of contract assets; and, in 2023, the fair value of liability classified Contract Consideration Convertible Notes Payable.

Recent Accounting Pronouncements

Changes to U.S. GAAP are established by the FASB. We evaluate the applicability and impact of all authoritative guidance issued by the FASB. Guidance not listed below was assessed and determined to be either not applicable, clarifications of items listed below, immaterial or already adopted by the Company.

New Accounting Standards Issued and Not Adopted as of March 31, 2024

The FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”). The amendments under ASU 2023-09 were created as a response to requests from investors, lenders, creditors and other parties to enhance transparency and effectiveness of tax disclosures to help them better assess how an entity’s operations and related tax risks affect an entity’s tax rate and potential future cash flows. ASU 2023-09 requires that entities annually disclose the amount of taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions and that those amounts are also disaggregated by individual jurisdictions equal to or greater than 5% of total income taxes paid (net of funds received). ASU 2023-09 adds a requirement that entities disaggregate income (loss) from continuing operations before income tax expense (benefit) between domestic and foreign. The amendments also require entities to disaggregate income tax expense (benefit) by federal, state and foreign jurisdictions.

The amendments under ASU 2023-09 also remove certain prior requirements. Public business entities are no longer required to disclose the nature and estimate of change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate cannot be determined. In addition public business entities are no longer required to disclose the cumulative amount of each type of temporary difference for which a deferred tax liability has not been recognized due to the exception to recognizing deferred taxes related to subsidiaries and corporate joint ventures. ASU 2023-09 goes into effect for annual periods beginning after December 15, 2024 and early adoption is permitted for annual financial statements not yet issued or made

---

available for issuance. Adoption of the ASU is on a prospective basis, with the option to apply retrospectively. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures.

The FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures.” This standard improves reportable segment disclosure requirements through enhanced disclosures around significant segment expenses. The amendments under this standard require interim and annual disclosures of significant segment expenses regularly provided to the chief operating decision maker (“CODM”). In addition, public entities are required to disclose the amount of “other segment items” by segment and their composition; make annual disclosures about a reportable segment’s profit/loss and assets; and clarify if the CODM uses more than one measure of a segment’s profit or loss in assessing performance and resource allocation and disclose the name and title of the CODM. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and the amendments are applied retrospectively to all prior periods presented. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures.

Disaggregation of Revenue

The Company differentiates revenue based on whether the source of revenue is attributable to product sales or service revenue.

Total revenue disaggregated by revenue source is as follows (in thousands):

									Three months ended March 31,
															2024						2023
Revenue:
Products (1)															$	39,106					$	46,767
Services															1,268						1,240
															$	40,374					$	48,007

(1) Product revenue includes sales to related parties as described in Note 16, “Related Party Transactions.”

Disaggregation of Cost of Sales

The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs which cannot be directly attributable to either tangible goods or services.

Total cost of sales disaggregated is as follows (in thousands):

									Three months ended March 31,
															2024						2023
Cost of sales:
Tangible goods sold															$	27,025					$	41,529
Services															94						141
Other															4,434						4,457
															$	31,553					$	46,127

Other cost of sales represent costs directly associated with the generation of revenue but which cannot be attributed directly to tangible goods sold or services. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs.

---

Cost of sales split between external and related party sales is as follows (in thousands):

									Three months ended March 31,
															2024						2023
Cost of sales:
Cost of sales for external customers															$	12,952					$	11,196
Cost of sales for related parties															18,601						34,931
															$	31,553					$	46,127

Contract assets are as follows (in thousands):

			March 31, 2024						December 31, 2023
Contract assets			$	83,060					$	83,060
Less accumulated amortization			(9,672)						(8,405)
Contract assets, net			73,388						74,655
Less current contract assets			(7,019)						(5,836)
Contract assets, long term			$	66,369					$	68,820

In connection with entering into the Initial ProFrac Agreement and Amended ProFrac Agreement on February 2, 2022 and May 17, 2022, respectively, as discussed in Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions,” the Company recognized contract assets of $10.0 million and $69.5 million, respectively, and associated fees of $3.6 million. As of March 31, 2024 and December 31, 2023, $66.4 million and $68.8 million, respectively, of the contract assets were classified as long term based upon our estimate of the forecasted revenues from the ProFrac Agreement which will not be realized within the next twelve months of the ProFrac Agreement. The Company’s estimate of the timing of the future contract revenues is evaluated on a quarterly basis.

During the three months ended March 31, 2024 and 2023, the Company recognized $1.3 million and $1.3 million, respectively, of contract assets amortization which is recorded as a reduction of the transaction price included in the related party revenue in the consolidated statement of operations. The below table reflects our estimated amortization per year (in thousands) based on the Company’s current forecasted revenues from the ProFrac Agreement.

Years ending December 31,						Amortization
2024 (excluding the three months ended March 31, 2024)						$	5,029
2025						8,749
2026						9,538
2027						9,538
2028						9,538
Thereafter through May 2032						30,996
Total contract assets						$	73,388

Based on our tests of recoverability, we did not recognize any impairment of such contract assets as of March 31, 2024.

---

Inventories are as follows (in thousands):

			March 31, 2024						December 31, 2023
Raw materials			$	5,618					$	5,299
Finished goods			14,281						13,660
Inventories			19,899						18,959
Less reserve for excess and obsolete inventory			(6,028)						(6,121)
Inventories, net			$	13,871					$	12,838

Property and equipment are as follows (in thousands):

			March 31, 2024						December 31, 2023
Land			$	886					$	886
Land improvements			520						520
Buildings and leasehold improvements			5,487						5,483
Machinery and equipment			7,065						6,993
Furniture and fixtures			520						520
Transportation equipment			945						945
Computer equipment and software			1,772						1,696
Property and equipment			17,195						17,043
Less accumulated depreciation			(12,134)						(11,914)
Property and equipment, net			$	5,061					$	5,129

Depreciation expense totaled $0.2 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively.

The components of lease expense and supplemental cash flow information are as follows (in thousands):

									Three months ended March 31,
															2024						2023
Operating lease expense															$	784					$	869
Finance lease expense:
Amortization of assets															4						4
Interest on lease liabilities															—						1
Total finance lease expense															4						5
Short-term lease expense															259						41
Total lease expense															$	1,047					$	915
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases															$	1,654					$	1,365
Operating cash flows from finance leases															13						10
Financing cash flows from finance leases															—						1

---

Maturities of lease liabilities as of March 31, 2024 are as follows (in thousands):

Years ending December 31,						Operating Leases						Finance Leases
2024 (excluding the three months ended March 31, 2024)			$	2,073					$	13
2025						2,046						—
2026						1,732						—
2027						1,660						—
2028						1,518						—
Thereafter						2,815						—
Total lease payments						$	11,844					$	13
Less: Interest						(2,640)						—
Present value of lease liabilities						$	9,204					$	13

Supplemental balance sheet information related to leases is as follows (in thousands):

			March 31, 2024						December 31, 2023
Operating Leases
Operating lease right-of-use assets			$	4,336					$	5,030
Current portion of operating lease liabilities			2,083						2,449
Long-term operating lease liabilities			7,121						7,676
Total operating lease liabilities			$	9,204					$	10,125
Finance Leases
Property and equipment			$	147					$	147
Accumulated depreciation			(74)						(70)
Property and equipment, net			$	73					$	77
Current portion of finance lease liabilities			$	13					$	22
Long-term finance lease liabilities			—						—
Total finance lease liabilities			$	13					$	22
Weighted Average Remaining Lease Term
Operating leases			5.6 years						5.5 years
Finance leases			0.3 years						0.6 years
Weighted Average Discount Rate
Operating leases			9.4		%				9.5		%
Finance leases			8.5		%				8.5		%

---

Sublease Income

On April 1, 2023, the Company entered into an agreement to sublease its office and lab space in Houston, Texas beginning September 1, 2023 and continuing until October 30, 2030. The rental income from the sublease is included in the Company’s statement of operations in Other income (expense), net, and offsets the monthly rental expense of $86 thousand from the Company’s lease of the facility from the landlord. Sublease rental income for future years are as follows (in thousands):

Years ending December 31,						Rental Income
2024 (excluding the three months ended March 31, 2024)			$	575
2025						767
2026						767
2027						767
2028						767
Thereafter						1,406
Total rental income						$	5,049

Current accrued liabilities are as follows (in thousands):

			March 31, 2024						December 31, 2023
Severance costs			$	417					$	648
Payroll and benefits			937						2,138
Legal costs			201						37
Contingent liability for earn-out provision			30						56
Deferred revenue, current			303						550
Taxes other than income taxes			182						656
Other			1,295						1,805
Total current accrued liabilities			$	3,365					$	5,890

Asset Based Loan

On August 14, 2023, the Company entered into a 24-month revolving loan and security agreement in connection with an asset-based loan (the “ABL”). The ABL is classified, under ASC 470, as current debt on our consolidated balance sheet due to the nature of the payment arrangements where the lender is paid from customer payments received into the Company’s collections account. The ABL provides up to $13.8 million of credit availability, which is limited by a borrowing base consisting of (i) 85% of eligible accounts receivable, plus (ii) 60% of the value of eligible inventory not to exceed 100% of the eligible accounts receivable.

As of March 31, 2024, the Company had $3.1 million outstanding with approximately $6.0 million of available borrowings under the ABL. During the three months ended March 31, 2024, the Company incurred $0.2 million in interest and fees related to the ABL. As of March 31, 2024, the Company recorded $0.1 million of amortized deferred financing costs related to the ABL.

Borrowings under the ABL bear interest at the Wall Street Journal Prime Rate (subject to a floor of 5.5%) plus 2.5% per annum. The interest rate under the ABL was 11.0% as of March 31, 2024. The ABL contains an annual commitment fee equal to 1.0% of the ABL’s borrowing base. Additionally, the Company will be assessed a non-usage fee of 0.25% per quarter based on the difference between the average daily outstanding balance and the borrowing base limit of the ABL. If the ABL is terminated prior to the end of its 24-month term, the Company is required to pay an early termination fee of 2.50% of the borrowing base limit of the ABL (if terminated with more than 12 months remaining until the maturity date) or 1.50% of the borrowing base limit of the ABL (if terminated with less than 12 months remaining until the maturity date).

---

The ABL contains customary representations, warranties, covenants and events of default, the occurrence of which would permit the lender to accelerate the payment of any amounts borrowed. The ABL requires the Company to maintain a minimum Tangible Net Worth (as defined in the ABL) of not less than $11 million. In addition, the ABL provides the lender a blanket security interest on all or substantially all of the Company’s assets. The Company was in compliance with all of the covenants under the ABL as of March 31, 2024.

Paycheck Protection Program Loan

In April 2020, the Company received a $4.8 million loan (the “Flotek PPP loan”) under the Paycheck Protection Program (“PPP”), which was created through the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). In October 2021, the Flotek PPP loan maturity date was extended from April 15, 2022 to April 15, 2025. On January 5, 2023, the Company received notice from the SBA that $4.4 million of the $4.8 million principal amount and accrued interest to that date of $0.1 million were forgiven. The remaining principal amount of $0.4 million and accrued interest is to be repaid in monthly installments of $15 thousand over the remaining term of the loan through April 15, 2025, beginning on March 15, 2023. The forgiveness of the Flotek PPP loan is accounted for as an extinguishment of the debt and the Company recorded a $4.5 million gain in the three months ended March 31, 2023, comprising the principal amount forgiven of $4.4 million and accrued interest of $0.1 million.

Long-term debt, including current portion, is as follows (in thousands):

			March 31, 2024						December 31, 2023
Flotek PPP loan			$	194					$	239
Less current maturities			(179)						(179)
Total long-term debt, net of current portion			$	15					$	60

Loan repayments are scheduled as follows (in thousands):

Years ending December 31,						Repayment
2024 (excluding the three months ended March 31, 2024)						$	134
2025						60
Total Flotek PPP loan						$	194

Convertible Notes Payable

On February 2, 2022, Flotek entered into a Private Investment in Public Equity transaction (the “PIPE transaction”) with a consortium of investors to secure growth capital for the Company. Pursuant to the PIPE transaction, Flotek issued $21.2 million in aggregate initial principal amount of Convertible Notes Payable for net cash proceeds of approximately $20.1 million (the “Convertible Notes Payable”). The investors were ProFrac Holdings, LLC, Burlington Ventures Ltd., entities associated with North Sound Management, certain funds associated with one of Flotek's directors including the D3 Family Fund and the D3 Bulldog Fund, and Firestorm Capital LLC. The Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum, had a maturity of one year, and were convertible into common stock of Flotek or Pre-Funded Warrants to purchase common stock of Flotek, (a) at the holder's option at any time prior to maturity, at a price of $1.088125 per share on a pre-Reverse Stock Split basis, (b) at Flotek's option, if the volume-weighted average trading price of Flotek's common stock equals or exceeds $2.50 per share on a pre-Reverse Stock Split basis, or $1.741 per share on a pre-Reverse Stock Split basis, for 20 trading days during a 30 consecutive trading day period, or (c) at maturity, at a price of $0.8705 per share on a pre-Reverse Stock Split basis. On March 21, 2022, a portion of of the Convertible Notes Payable, plus accrued paid-in-kind interest thereon, were converted at the holder’s option into shares of common stock. The issuance cost was amortized on a straight-line basis over the term of the Convertible Notes Payable and the amortization was included in interest expense in the unaudited condensed consolidated statements of operations. The carrying value was recorded as additional paid in capital.

Upon maturity on February 2, 2023, the Convertible Notes Payable, excluding those held by ProFrac Holdings, LLC, with a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million, were converted on a pre-Reverse Stock Split basis into 10,335,840 shares of common stock (1,722,640 shares of the Company’s common stock on a post-Reverse Stock Split basis) at a price of $0.8705 per share.

---

The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share and were recorded as additional paid in capital upon conversion.

Initial ProFrac Agreement Contract Consideration Convertible Notes Payable

On February 2, 2022, the Company entered into a long-term supply agreement with ProFrac Services, LLC (the “Initial ProFrac Agreement”), a subsidiary of ProFrac Holdings LLC, in exchange for $10 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Initial ProFrac Agreement Contract Consideration Convertible Notes Payable”), under the same terms as the Convertible Notes Payable issued in the PIPE transaction described above, including paid-in-kind interest at a rate of 10% per annum and conversion features.

The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $10.0 million on the issuance date with a corresponding contract asset.

On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, remeasured to and carried at a fair value of $15.1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants with an exercise price of $0.0001 per share (see Note 10, “Fair Value Measurements”) and were recorded as additional paid in capital upon conversion.

Amended ProFrac Agreement Contract Consideration Convertible Notes Payable

On May 17, 2022, the Company entered into an amendment to the Initial ProFrac Agreement (the “Amended ProFrac Agreement” and collectively with the Initial ProFrac Agreement, the “ProFrac Agreement”) upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Amended ProFrac Agreement Contract Consideration Convertible Notes Payable”) to ProFrac. The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum.

The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $69.5 million on the issuance date with a corresponding contract asset.

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement.

•Level 1 — Quoted prices in active markets for identical assets or liabilities;

•Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

•Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.

Fair Value of Other Financial Instruments

The carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accrued liabilities, accounts payable and ABL approximate fair value due to the short-term nature of these accounts.

---

Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the Company’s liabilities that are measured at fair value on a recurring basis and the level within the fair value hierarchy (in thousands):

												March 31,																		December 31,
			Level 1			Level 2			Level 3			2024						Level 1			Level 2			Level 3						2023
Contingent earnout consideration			$	—		$	—		$	30		$	30					$	—		$	—		$	56					$	56
Total			$	—		$	—		$	30		$	30					$	—		$	—		$	56					$	56

Contingent Earnout Consideration Key Inputs

The estimated fair value of the remaining stock performance earn-out provision, with respect to the JP3 transaction, is included in accrued liabilities as of March 31, 2024 and December 31, 2023. The estimated fair value of the earn-out provision at the end of each period was valued using a Monte Carlo model analyzing 20,000 simulations performed using Geometric Brownian Motion with inputs such as risk-neutral expected growth and volatility.

			March 31, 2024			December 31, 2023
Risk-free interest rate			4.97		%	4.58		%
Expected volatility			70.0		%	70.0		%
Term until liquidation (years)			1.13			1.38
Stock price (pre-Reverse Stock Split basis)			$	3.74		$	3.92
Discount rate			13.67		%	11.86		%

Initial ProFrac Agreement Contract Consideration Notes Payable Key Inputs

The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were measured at fair value at issuance and on a recurring basis. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable had an initial fair value of $10.0 million on February 2, 2022. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were classified as Level 2 at the initial measurement upon issuance due to the use of a quoted price for a similar liability at that date (the PIPE transaction), and subsequently classified as Level 3 due to the use of unobservable inputs.

On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, upon maturity, to a fair value of $15.1 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $1.19, on the date of conversion. The fair value adjustment was a $0.8 million increase for the three months ended March 31, 2023.

Amended ProFrac Agreement Contract Consideration Convertible Notes Payable Key Inputs

On May 17, 2022, the Company measured the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable classified as Level 3 using a Monte Carlo simulation at an estimated fair value of $69.5 million. The Company reduced the discount rate assumed due to the reduced likelihood of occurrence of any of the default events in the shorter term remaining on the notes. The estimated value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable as of March 31, 2023 was remeasured using a Monte Carlo simulation resulting in a gain in fair value of Contract Consideration Convertible Notes Payable of $26.9 million for the three months ended March 31, 2023.

On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, at maturity, to a fair value of $40.6 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $0.64, on the date of conversion.

Assets Measured at Fair Value on a Nonrecurring Basis

The Company’s non-financial assets, including property and equipment and operating lease ROU assets, are measured at fair value on a non-recurring basis and are subject to adjustment to their fair value in certain circumstances.

---

Level 3 Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the changes in balances of liabilities for the three months ended March 31, 2024 and 2023 classified as Level 3 (in thousands):

									Three months ended March 31,
															2024						2023
Balance - beginning of period															$	56					$	84,153
Increase in principal of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest															—						85
Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest															—						1,331
Change in fair value of contingent earnout consideration															(26)						(358)
Change in fair value of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable															—						786
Change in fair value of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable															—						(26,881)
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity															—						(15,092)
Balance - end of period															$	30					$	44,024

The income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21% to income (loss) before income tax for the reasons set forth below:

									Three months ended March 31,
															2024						2023
U.S. federal statutory tax rate															21.0		%				21.0		%
State income taxes, net of federal benefit															13.5						—
Non-U.S. income taxed at different rates															(5.2)						0.1
Increase (reduction) in tax benefit related to stock-based awards															1.2						0.4
Change in valuation allowance															(18.8)						(20.5)
Permanent differences related to CARES Act															—						(1.1)
Non-deductible expenses															1.8						0.1
Effective income tax rate															13.5		%				—		%

As of March 31, 2024, the Company had U.S. net operating loss carryforwards (“NOLs”) of $194.8 million, including $46.4 million expiring in various amounts from 2029 through 2037 which can offset 100% of taxable income and $148.4 million that has an indefinite carryforward period which can offset 80% of taxable income per year. Additionally, the Company has an estimated $96.1 million in certain state NOL carryforwards, $0.7 million in Section 163(j) interest limitation carryforwards and $3.8 million in tax credit carryforwards. As a result of the ownership change experienced in 2023, the Company’s ability to use NOLs to reduce taxable income is generally limited by Section 382 of the Internal Revenue Code of 1986 to an annual amount of $3.5 million plus an uplift of $24.5 million. NOLs that exceed the Section 382 limitation in any year continue to be allowed as carryforwards until they expire and can be used to offset taxable income for years within the carryover period subject to the limitation in each year. The Company’s use of NOLs arising after the date of the ownership change are not impacted by the Section 382 limitation. If the Company does not generate a sufficient level of taxable income prior to the expiration of the pre-2018 NOL carryforward periods, then the ability to apply those NOLs as offsets to future taxable income is lost. Based on an analysis of the Section 382 limitation, the Company estimates that $31.3 million of the state NOL carryforwards (subject to additional state-by-state analysis) and $3.8 million of the tax credit carryforwards will expire unutilized. Although the ownership change will significantly limit the ability of the Company to utilize the pre-change net operating losses and credits, the Company does not expect a significant impact to its financial statements given the valuation allowance that is recorded to estimate the realizability of the deferred tax assets.

---

Litigation

The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity.

Other Commitments and Contingencies

The Company is subject to concentrations of credit risk within trade accounts receivable, and related party accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in three major U.S. financial institutions and balances often exceed insurable amounts.

Reverse stock split

On September 14, 2023, the Company announced that the Board of Directors approved a reverse stock split of its common stock at a ratio of 1-to-6 (“Reverse Stock Split”). The Reverse Stock Split was completed on September 25, 2023 and resulted in 184,438,695 issued and outstanding shares of common stock being converted into 30,772,837 shares of common stock.

The Reverse Stock Split had no effect on the par value or on the number of authorized shares of common stock. The Company issued one whole share of common stock to any shareholder that would have received a fractional share as a result of the Reverse Stock Split. Therefore, no fractional shares were issued in connection with the Reverse Stock Split and no cash or other consideration was paid in connection with any fractional shares that resulted from the Reverse Stock Split.

The Company adjusted the number of outstanding shares of common stock and treasury stock on the consolidated balance sheet and in the statement of changes in stockholders’ equity for all periods presented to reflect the impacts of the Reverse Stock Split. Where we disclose the number of shares of common stock within the footnotes to the consolidated financial statements we have presented both the pre-Reverse Stock Split and post-Reverse Stock Split amount as denoted.

Unless otherwise noted, all references in the consolidated financial statements and notes to condensed consolidated financial statements to the number of shares, per share data, restricted stock and stock option data have been retroactively adjusted to give effect to the Reverse Stock Split.

Conversion of Convertible Notes Payable

On February 2, 2023, the Convertible Notes Payable pursuant to the PIPE transaction discussed in Note 9, “Debt and Convertible Notes Payable”, excluding those held by ProFrac Holdings, LLC, were converted on a pre-Reverse Stock Split basis, upon maturity, into 10,335,840 shares of common stock (1,722,640 shares of common stock on a post-Reverse Stock Split basis) at a price of $0.8705 per share. The Convertible Notes Payable converted into common stock shares had a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million and were recorded as additional paid-in-capital upon conversion.

The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Convertible Notes Payable held by ProFrac Holding, LLC were exercised and the Company issued, on a pre-Reverse Stock Split basis, 12,683,280 shares of the Company’s common stock (2,113,880 shares of the Company’s common stock on a post-Reverse Stock Split basis).

On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable”, remeasured to a fair value of $15.1 million upon maturity, were converted on a pre-Reverse Stock Split basis, into 12,683,281 February 2023 Warrants and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were exercised and the Company issued on a pre-Reverse Stock Split basis, 12,683,281 shares of the Company’s common stock (2,113,881 shares of the Company’s common stock on a post-Reverse Stock Split basis).

---

On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable” were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (10,582,821 shares of common stock on a post-Reverse Stock Split basis). The Contract Consideration Convertible Notes Payable converted into common stock shares, remeasured to a fair value of $40.6 million upon maturity, were recorded as additional paid-in-capital.

Pre-Funded Warrants

On June 21, 2022, ProFrac Holdings II, LLC paid $19.5 million for Pre-Funded Warrants (the “June 2022 Warrants”) of the Company. The June 2022 Warrants permit ProFrac Holdings II, LLC to purchase on a pre-Reverse Stock Split basis 13,104,839 shares of common stock of the Company (2,184,140 shares of the Company’s common stock on a post-Reverse Stock Split basis) at an exercise price equal to $0.0001 per share, subject to a $4.5 million exercise fee.

Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period, which includes the February 2023 Warrants (See Note 9, “Debt and Convertible Notes Payable”, and Note 13, “Stockholders’ Equity”). Diluted earnings (loss) per common share is calculated by dividing the adjusted net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive common share equivalents consist of incremental shares of common stock issuable upon conversion of convertible notes payable, exercise of stock warrants and vesting and settlement of stock awards. The dilutive effect of non-vested stock issued under share‑based compensation plans, shares issuable under the Employee Stock Purchase Plan (ESPP), employee stock options outstanding, and the Pre-Funded stock warrants are computed using the treasury stock method. The dilutive effect of the Convertible Notes is computed using the if‑converted method.

---

For all periods presented in the table below, weighted average shares and earnings (loss) per share reflect the effects of the Reverse Stock Split. The calculation of the basic and diluted earnings (loss) per share for the three months ended March 31, 2024 and 2023 is as follows (in thousands):

									Three months ended March 31,
																		2024						2023
Numerator:
Net income for basic earnings per share																		$	1,562					$	21,343
Adjustments to net income available to shareholders
Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable																		—						1,571
Valuation gain on Contract Consideration Convertible Notes Payable carried at fair value																		—						(26,095)
Adjusted net income (loss) for diluted earnings per share																		$	1,562					$	(3,181)
Denominator:
Basic weighted average shares outstanding																		29,431						16,468
Dilutive effect of convertible notes payable																		—						9,994
Dilutive effect of warrants outstanding																		779						—
Dilutive effect of stock options and restricted shares																		106						—
Diluted weighted average shares outstanding																		30,316						26,462
Basic earnings per share																		$	0.05					$	1.30
Diluted earnings (loss) per share																		$	0.05					$	(0.12)
Anti-dilutive incremental shares excluded from denominator for diluted earnings computation
Average number of diluted shares for June 2022 stock warrants (1)																		—						1,500
Average number of diluted shares for options and restricted stock (1)																		—						170

(1) These items were not included in the dilution calculation for the three months ended March 31, 2023 due to their anti-dilutive effect as it would reduce the loss per share.

Supplemental cash flow information is as follows (in thousands):

        

			Three months ended March 31,
			2024						2023
Supplemental cash flow information:
Interest paid			$	210					$	18
Supplemental non cash financing and investing activities:
Conversion of convertible notes payable to common stock			—						8,996
Conversion of convertible notes payable to February 2023 Warrants			—						11,040
Conversion of Initial Contract Consideration Convertible Notes Payable to February 2023 Warrants			—						15,092

---

On February 2, 2022, the Company entered into the Initial ProFrac Agreement, upon issuance of $10 million in aggregate principal amount of the convertible notes (the “Contract Consideration Convertible Notes Payable”) to ProFrac Holdings LLC (see Note 9, “Debt and Convertible Notes Payable”). Under the Initial ProFrac Agreement, ProFrac Services, LLC is obligated to order chemicals from the Company at least equal to the greater of (a) the chemicals required for 33% of ProFrac Services, LLC’s hydraulic fracturing fleets and (b) a baseline measured by the first ten hydraulic fracturing fleets deployed by ProFrac Services, LLC during the term of the Initial ProFrac Agreement. If the minimum volumes are not achieved in any given year, ProFrac Services LLC shall pay to the Company, as liquidated damages an amount equal to twenty-five percent (25%) of the difference between (i) the aggregate purchase price of the quantity of products comprising the minimum purchase obligation and (ii) the actual purchased volume during such calendar year (“Contract Shortfall Fees”).

On May 17, 2022, the Company entered into the Amended ProFrac Agreement upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”). The Initial ProFrac Agreement was amended to (a) increase ProFrac Services LLC’s minimum purchase obligation for each year to the greater of 70% of ProFrac Services LLC’s requirements and a baseline measured by ProFrac Services, LLC’s first 30 hydraulic fracturing fleets, and (b) increase the term to 10 years.

On February 2, 2023, the Company entered into an amendment to the ProFrac Agreement (the “Amended ProFrac Agreement No. 2”). The Amended ProFrac Agreement No. 2 has an effective date of January 1, 2023. The ProFrac Agreement was amended to (1) provide a ramp-up period from January 1, 2023 to May 31, 2023 for ProFrac Services, LLC to increase the number of active hydraulic fracturing fleets to 30 fleets, (2) waive any Contract Shortfall Fee payment relating to any potential order shortfall prior to January 1, 2023, (3) add additional fees to certain products, and (4) provide margin increases based on margins with non-ProFrac customers.

The current measurement period for Contract Shortfall Fees is January 1, 2024 through December 31, 2024. The Company does not expect that the minimum purchase requirements will be met during the current measurement period, and as a result, the revenues for three months ended March 31, 2024 reflect variable consideration for Contract Shortfall Fees of $8.7 million, which will be due in the first quarter of 2025 under the terms of the ProFrac Agreement. Because the measurement period for 2023 was June 1, 2023 through December 31, 2023, there are no Contract Shortfall Fees reflected in revenues for the first quarter of 2023.

On February 2, 2023, the Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”) and subsequently exercised on September 6, 2023.

On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, with a carrying value of $11.0 million, including accrued interest of $1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants and subsequently exercised on September 6, 2023 (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, as of February 2, 2023, was $15.1 million (see Note 10, “Fair Value Measurements”).

On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, as of May 17, 2023 was $40.6 million (see Note 10, “Fair Value Measurements”). As a result of the Reverse Stock Split, these shares were converted into 10,582,821 common shares.

During the three months ended March 31, 2024 and 2023, the Company’s revenues from ProFrac Services, LLC were $27.2 million and $36.4 million, respectively. For the three months ended March 31, 2024 and 2023, these revenues were net of amortization of contract assets of $1.3 million and $1.3 million, respectively. Cost of sales attributable to these revenues were $18.6 million and $34.9 million, respectively for the three months ended March 31, 2024 and 2023. As of March 31, 2024 and December 31, 2023 our accounts receivable from ProFrac Services, LLC was $38.7 million and $34.6 million, respectively which is recorded in accounts receivable, related party on the consolidated balance sheet. During the three months ended March 31, 2024, the Company collected $15.1 million of variable consideration of the $20.1 million related to the 2023 Contract Shortfall Fees which were included in accounts receivable, related party as of December 31, 2023. The remaining total of $5.0 million was collected subsequent to March 31, 2024.

---

Segment Information

Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the chief operating decision-maker in deciding how to allocate resources and assess performance. The operations of the Company are categorized into the following reportable segments:

Chemistry Technologies. The CT segment includes green specialty chemistries, logistics and technology services, which enable its customers to pursue improved efficiencies and performance throughout the life cycle of their wells, and also helping customers improve their ESG and operational goals. Customers of the CT segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies.

Data Analytics. The DA segment includes the design, development, production, sale and support of equipment and services that create and provide valuable information on the composition and properties of energy customers’ hydrocarbon fluids. The company markets products and services that support in-line data analysis of hydrocarbon components and properties. Customers of the DA segment span across the entire oil and gas market, from upstream production to midstream facilities to refineries and distribution networks.

Performance is based upon a variety of criteria. The primary financial measure is segment operating income (loss). Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segments.

---

Summarized financial information of the reportable segments is as follows (in thousands):

As of and for the three months ended March 31,			Chemistry Technologies						Data Analytics						Corporate and Other						Total
2024
Revenue from external customers
Products			$	11,159					$	933					$	—					$	12,092
Services			526						562						—						1,088
Total revenue from external customers			11,685						1,495						—						13,180
Revenue from related party
Products			27,014						—						—						27,014
Services			—						180						—						180
Total revenue from related parties			27,014						180						—						27,194
Gross profit			8,401						420						—						8,821
Income (loss) from operations			6,106						(424)						(3,574)						2,108
Depreciation			159						35						26						220
Interest on ABL			—						—						181						181
Other interest			—						—						97						97
Income tax			—						—						242						242
Additions to long-lived assets			147						—						5						152
2023
Revenue from external customers
Products			$	8,561					$	1,941					$	—					$	10,502
Services			664						486						—						1,150
Total revenue from external customers			9,225						2,427						—						11,652
Revenue from related party
Products			36,265						—						—						36,265
Services			—						90												90
Total revenue from related parties			36,265						90						—						36,355
Gross profit			434						1,446						—						1,880
Change in fair value of Contract Consideration Convertible Notes Payable			(26,095)						—						—						(26,095)
Income (loss) from operations			23,379						457						(5,325)						18,511
Paid-in-kind interest on Contract Consideration Convertible Notes Payable			1,416						—						—						1,416
Paid-in-kind interest on convertible notes payable			—						—						155						155
Depreciation			157						18						1						176
Income tax			—						—						9						9
Additions to long-lived assets			30						95						32						157

---

Assets of the Company by reportable segments are as follows (in thousands):

			March 31, 2024						December 31, 2023
Chemistry Technologies			$	139,551					$	138,559
Data Analytics			6,253						6,604
Corporate and Other			10,046						12,350
Total assets			$	155,850					$	157,513

Geographic Information

Revenue by country is based on the location where services are provided and products are sold. For the three months ended March 31, 2024 and 2023 no individual countries other than the U.S. accounted for more than 10% of revenue. Revenue by geographic location is as follows (in thousands):

									Three months ended March 31,
															2024						2023
U.S. (1)															$	39,259					$	46,126
UAE															741						1,403
Other countries															374						478
Total revenue															$	40,374					$	48,007

(1) Includes revenue from related party

Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements.

Major Customers

Revenue from major customers, as a percentage of consolidated revenue, is as follows (in thousands):

						Revenue						% of Total Revenue
Three months ended March 31, 2024
Customer A (Related Party)						$	27,194					67.4		%
Three months ended March 31, 2023
Customer A (Related Party)						$	36,355					75.7		%

The concentration with ProFrac Services, LLC and in the oil and gas industry increases credit, commodity and business risk.

Major Suppliers

Expenditure with major suppliers, as a percentage of consolidated supplier expenditure, is as follows (in thousands):

Three months ended March 31,						Expenditure						% of Total Expenditure
2024
Supplier A						$	7,747					29.7		%
Supplier B						5,020						19.2		%
2023
Supplier A						$	16,954					40.1		%
Supplier B						7,145						16.9		%
Supplier C						4,504						10.6		%

---

---

---

---

---

---

---

---

---

---

---

v3.24.1.u1

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	May 06, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-13270
Entity Registrant Name	FLOTEK INDUSTRIES INC/CN
Entity Incorporation, State	DE
Entity Tax Identification Number	90-0023731
Entity Address, Street	5775 N. Sam Houston Parkway W., Suite 400,
Entity Address, City	Houston,
Entity Address, State	TX
Entity Address, Postal Zip Code	77086
City Area Code	713
Local Phone Number	849-9911
Title of each class	Common Stock, $0.0001 par value
Trading Symbol(s)	FTK
Name of each exchange on which registered	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		29,656,821
Entity Central Index Key	0000928054
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

v3.24.1.u1

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,219	$ 5,851
Restricted cash	100	102
Inventories, net	13,871	12,838
Other current assets	2,686	3,564
Current contract assets	7,019	5,836
Total current assets	78,268	76,447
Long-term contract assets	66,369	68,820
Property and equipment, net	5,061	5,129
Operating lease right-of-use assets	4,336	5,030
Deferred tax assets, net	91	300
Other long-term assets	1,725	1,787
TOTAL ASSETS	155,850	157,513
Current liabilities:
Accounts payable	35,952	31,705
Accrued liabilities	3,365	5,890
Income taxes payable	78	45
Current portion of operating lease liabilities	2,083	2,449
Current portion of finance lease liabilities	13	22
Asset-based loan	3,111	7,492
Current portion of long-term debt	179	179
Total current liabilities	44,781	47,782
Deferred revenue, long-term	35	35
Long-term operating lease liabilities	7,121	7,676
Long-term debt	15	60
TOTAL LIABILITIES	51,952	55,553
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value, 240,000,000 shares authorized; 30,772,837 shares issued and 29,661,130 shares outstanding at March 31, 2024; 30,772,837 shares issued and 29,664,130 shares outstanding at December 31, 2023 (As adjusted, see Note 13)	3	3
Additional paid-in capital (As adjusted, see Note 13)	463,484	463,140
Accumulated other comprehensive income	169	127
Accumulated deficit	(325,244)	(326,806)
Treasury stock, at cost; 1,111,707 and 1,108,707 shares at March 31, 2024 and December 31, 2023, respectively (As adjusted, see Note 13)	(34,514)	(34,504)
Total stockholders’ equity	103,898	101,960
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	155,850	157,513
Third Party
Current assets:
Accounts receivable	10,718	13,687
Related Party
Current assets:
Accounts receivable	$ 38,655	$ 34,569

v3.24.1.u1

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounts receivable, allowance for doubtful accounts	$ 372	$ 745
Preferred stock, at par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000	100,000
Preferred stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	240,000,000	240,000,000
Common stock, shares issued (in shares)	30,772,837	30,772,837
Common stock, shares outstanding (in shares)	29,661,130	29,664,130
Treasury stock, shares (in shares)	1,111,707	1,108,707
Third Party
Accounts receivable, allowance for doubtful accounts	$ 374	$ 745
Related Party
Accounts receivable, allowance for doubtful accounts	$ 0	$ 0

v3.24.1.u1

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenues	$ 40,374	$ 48,007
Cost of sales	31,553	46,127
Gross profit	8,821	1,880
Operating costs and expenses:
Selling, general, and administrative	6,084	6,451
Depreciation	220	176
Research and development	406	614
Severance costs	3	2,223
Gain in fair value of Contract Consideration Convertible Notes Payable	0	(26,095)
Total operating costs and expenses	6,713	(16,631)
Income from operations	2,108	18,511
Other income (expense):
Paycheck protection plan loan forgiveness	0	4,522
Interest expense	(278)	(1,672)
Other expense, net	(26)	(9)
Total other income (expense)	(304)	2,841
Income before income taxes	1,804	21,352
Income tax expense	(242)	(9)
Net income	$ 1,562	$ 21,343
Income (loss) per common share (As adjusted, see Note 14):
Basic (in dollars per share)	$ 0.05	$ 1.30
Diluted (in dollars per share)	$ 0.05	$ (0.12)
Weighted average common shares (As adjusted, see Note 14):
Weighted average common shares used in computing basic income (loss) per common share (in shares)	29,431	16,468
Weighted average common shares used in computing diluted income (loss) per common share (in shares)	30,316	26,462
Nonrelated Party
Revenue:
Total revenues	$ 13,180	$ 11,652
Cost of sales	12,952	11,196
Related Party
Revenue:
Total revenues	$ 27,194	$ 36,355

v3.24.1.u1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 1,562	$ 21,343
Other comprehensive income:
Foreign currency translation adjustment	42	(21)
Comprehensive income	$ 1,604	$ 21,322

v3.24.1.u1

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 1,562	$ 21,343
Adjustments to reconcile net income to net cash provided by operating activities:
Change in fair value of contingent consideration	(26)	(359)
Change in fair value of Contract Consideration Convertible Notes Payable	0	(26,095)
Amortization of convertible note issuance cost	0	83
Paid-in-kind interest expense	0	1,571
Amortization of contract assets	1,267	1,251
Depreciation	220	176
Amortization of asset-based loan origination costs	85	0
Provision for credit losses, net of recoveries	32	23	$ 138
Provision for excess and obsolete inventory	285	258
Lease expense	694	977
Stock compensation expense	311	(1,112)
Deferred income tax expense (benefit)	209	(6)
Paycheck protection plan loan forgiveness	0	(4,522)
Changes in current assets and liabilities:
Accounts receivable	2,937	3,504
Accounts receivable, related party	(4,086)	(3,546)
Inventories	(1,318)	(441)
Other assets	856	(470)
Accounts payable	4,246	8,554
Accrued liabilities	(2,499)	1,236
Operating lease liabilities	(921)	(1,190)
Income taxes payable	33	(87)
Interest payable	0	(8)
Net cash provided by operating activities	3,887	1,140
Cash flows from investing activities:
Capital expenditures	(152)	(157)
Net cash used in investing activities	(152)	(157)
Cash flows from financing activities:
Payment for forfeited stock options	0	(617)
Payments on long term debt	(45)	(15)
Proceeds from asset-based loan	38,800	0
Payments on asset-based loan	(43,181)	0
Payments to tax authorities for shares withheld from employees	(9)	(200)
Proceeds from issuance of stock	33	20
Payments for finance leases	(9)	(6)
Net cash used in financing activities	(4,411)	(818)
Effect of changes in exchange rates on cash and cash equivalents	42	(21)
Net change in cash and cash equivalents and restricted cash	(634)	144
Cash and cash equivalents at the beginning of period	5,851	12,290	12,290
Restricted cash at the beginning of period	102	100	100
Cash and cash equivalents and restricted cash at beginning of period	5,953	12,390	12,390
Cash and cash equivalents at end of period	5,219	12,433	5,851
Restricted cash at the end of period	100	101	102
Cash and cash equivalents and restricted cash at end of period	$ 5,319	$ 12,534	$ 5,953

v3.24.1.u1

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		13,986,000
Beginning balance at Dec. 31, 2022	$ 2,596	$ 1	$ (34,251)	$ 388,184	$ 181	$ (351,519)
Beginning balance (in shares) at Dec. 31, 2022			1,021,000
Increase (Decrease) in Equity
Net income	21,343					21,343
Foreign currency translation adjustment	(21)				(21)
Stock issued under employee stock purchase plan (in shares)			(4,000)
Stock issued under employee stock purchase plan	20			20
Restricted stock granted (in shares)		2,000
Restricted stock forfeited (in shares)		(7,000)	28,000
Restricted stock units vested (in shares)		64,000
Forfeited stock options purchased	(617)			(617)
Stock compensation expense	(1,112)			(1,112)
Shares withheld to cover taxes (in shares)		0	29,000
Shares withheld to cover taxes	(200)		$ (200)	0
Issuance of stock warrants, net of transaction fee	15,092			15,092
Equity contribution	11,040			11,040
Conversion of notes to common stock (in shares)		1,723,000
Conversion of notes to common stock	8,997	$ 1		8,996
Ending balance (in shares) at Mar. 31, 2023		15,768,000
Ending balance at Mar. 31, 2023	$ 57,138	$ 2	$ (34,451)	421,603	160	(330,176)
Ending balance (in shares) at Mar. 31, 2023			1,074,000
Beginning balance (in shares) at Dec. 31, 2023	30,772,837	30,773,000
Beginning balance at Dec. 31, 2023	$ 101,960	$ 3	$ (34,504)	463,140	127	(326,806)
Beginning balance (in shares) at Dec. 31, 2023	1,108,707		1,109,000
Increase (Decrease) in Equity
Net income	$ 1,562					1,562
Foreign currency translation adjustment	42				42
Stock issued under employee stock purchase plan (in shares)			(10,000)
Stock issued under employee stock purchase plan	33			33
Restricted stock forfeited (in shares)			11,000
Stock compensation expense	311			311
Shares withheld to cover taxes (in shares)		0	2,000
Shares withheld to cover taxes	$ (10)		$ (10)
Ending balance (in shares) at Mar. 31, 2024	30,772,837	30,773,000
Ending balance at Mar. 31, 2024	$ 103,898	$ 3	$ (34,514)	$ 463,484	$ 169	$ (325,244)
Ending balance (in shares) at Mar. 31, 2024	1,111,707		1,112,000

v3.24.1.u1

Organization and Nature of Operations	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Nature of Operations	Organization and Nature of Operations General Flotek creates unique solutions to reduce the environmental impact of energy on air, water, land and people. A technology-driven, specialty green chemistry and data company, Flotek helps customers across industrial and commercial markets improve their environmental performance. The Company serves specialty chemistry needs for both domestic and international energy markets. The Company’s Chemistry Technologies (“CT”) segment designs, develops, manufactures, packages and distributes green specialty chemicals that help customers improve their return on invested capital, lower operational costs and realize tangible environmental benefits aimed at enhancing the profitability of hydrocarbon producers. The Company’s Data Analytics (“DA”) segment aims to enable users to maximize the value of their hydrocarbon associated processes by providing analytics associated with their hydrocarbon streams in seconds rather than minutes or days. The real-time access to information prevents waste, reduces reprocessing and allows users to pursue automation of their hydrocarbon streams to maximize their profitability. The Company’s two operating segments, CT and DA, are supported by its Research & Innovation advanced laboratory capabilities. For further discussion of our operations and segments, see Note 17, “Business Segment, Geographic and Major Customer Information.” As used herein, “Flotek,” the “Company,” “we,” “our” and “us” refers to Flotek Industries, Inc. and/or the Company’s wholly-owned subsidiaries. The use of these terms is not intended to connote any particular corporate status or relationship. Sources and Uses of Liquidity These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company currently funds its operations with cash on hand, availability under the ABL (see Note 9, “Debt and Convertible Notes Payable”) and other liquid assets. The Company recognized $8.8 million and $1.6 million of gross profit and net income, respectively, during the three months ended March 31, 2024. While we believe that our cash, liquid assets, and availability under the ABL will provide us with sufficient financial resources to fund operations to meet our capital requirements and anticipated obligations as they become due, uncertainty surrounding the long-term stability and strength of the oil and gas markets could have a negative impact on our liquidity. The availability of capital is dependent on the Company’s operating cash flow, which is currently expected to be principally derived from the ProFrac Agreement (see Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions”). Related party revenues for the three months ended March 31, 2024 included Contract Shortfall Fees of $8.7 million. Related party receivables as of March 31, 2024 included accrued Contract Shortfall Fees of $13.7 million comprised of the remaining 2023 Contract Shortfall Fees payment of $5.0 million, which was collected in April 2024, and $8.7 million of accrued 2024 Contract Shortfall Fees, which will be due in the first quarter of 2025 under the terms of the ProFrac Agreement. Based upon our outlook for future cash flows from operations, which includes the collection of the Contract Shortfall Fees, combined with cash on hand and availability under the ABL, the Company believes it has sufficient financial resources to fund operations and meet its capital requirements and anticipated obligations as they become due in the next twelve months. While the Company cannot guarantee a sufficient level of cash flows in the future, the unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.

v3.24.1.u1

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements reflect all adjustments, in the opinion of management, necessary for the fair statement of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The financial statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the SEC regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s 2023 Annual Report. A copy of the 2023 Annual Report is available on the SEC’s website, www.sec.gov or on the Company’s website, www.flotekind.com. The information contained on the SEC’s website and the Company’s website does not form a part of this Quarterly Report. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries. Cash Equivalents Cash equivalents consist of highly liquid investments with maturities of three months or less at the date of purchase. Restricted Cash The Company’s restricted cash was $0.1 million and $0.1 million as of March 31, 2024 and December 31, 2023, respectively. The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain in accordance with the terms of its credit card program with a financial institution. Accounts Receivable and Allowance for Credit Losses Accounts receivable and accounts receivable, related party, arise from product sales and services and are stated at estimated net realizable value. This value incorporates an allowance for credit losses to reflect any loss anticipated on accounts receivable balances. The Company applies the current expected credit loss (CECL) model, which requires immediate recognition of expected credit losses over the contractual life of receivables and records the appropriate allowance for credit losses as a charge to Operating Cost and Expenses. The allowance for credit losses is based on a combination of the individual customer circumstances, credit conditions, and historical write-offs and collections. The Company writes off specific accounts receivable when they are determined to be uncollectible. The recovery of accounts receivable previously written off is recorded as a reduction to the allowance for credit losses charged to operating expense. The majority of the Company’s customers are engaged in the energy industry. The cyclical nature of the energy industry may affect customers’ operating performance and cash flows, which directly impact the Company’s ability to collect on outstanding obligations. Additionally, certain customers are located in international areas that are inherently subject to risks of economic, political, and civil instability, which can impact the collectability of receivables. Changes in the allowance for credit losses are as follows (in thousands):   March 31, 2024 December 31, 2023 Balance, beginning of year $ 745  $ 623  Charges to provision for credit losses, net of recoveries 32  138  Write-offs (405) (16) Balance, end of period $ 372  $ 745  As of March 31, 2024 and December 31, 2023 the Company had not recorded an allowance for credit losses for the related party accounts receivable, including ProFrac Services, LLC (see Note 16, “Related Party Transactions”). Contract Assets The Company’s contract assets represent consideration issued in the form of convertible notes (Contract Consideration Convertible Notes Payable as discussed in Note 9, “Debt and Convertible Notes Payable”) and other incremental costs related to obtaining the ProFrac Agreement (see Note 16, “Related Party Transactions”). The contract assets are amortized over the term of the ProFrac Agreement (originally 10 years) based on forecasted revenues as goods are transferred to ProFrac Services, LLC, and the amortization is presented as a reduction of the transaction price included in related party revenue in the consolidated statements of operations. The contract assets are tested for recoverability on a recurring basis and the Company will recognize an impairment loss to the extent that the carrying amount of the contract assets exceeds the amount of consideration the Company expects to receive in the future for the transfer of goods under the ProFrac Agreement less the direct costs that relate to providing those goods in the future. Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost determined by using the weighted-average cost method, or net realizable value. Finished goods inventories include raw materials, direct labor and production overhead. The Company periodically reviews inventories on hand and current market conditions to determine if the cost of raw materials and finished goods inventories exceed current market prices and impairs the cost basis of the inventory accordingly. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its net realizable value if those amounts are determined to be less than cost. Write-downs or write-offs of inventory are charged to cost of sales. Property and Equipment Property and equipment are stated at cost. Plant and equipment under finance leases are stated at the present value of the lease payments. The Company capitalizes costs associated with the acquisition of major software for internal use. The cost of ordinary maintenance and repair is charged to operating expense, while replacement of critical components and major improvements are capitalized. Depreciation or amortization of property and equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows: Buildings and leasehold improvements 2-30 years Machinery and equipment 7-10 years Furniture and fixtures 3 years Land improvements 20 years Transportation equipment 2-5 years Computer equipment and software 3-7 years Property and equipment, including ROU assets, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. If events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable, the Company first compares the carrying amount of an asset or asset group to the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset. If the carrying amount of an asset or asset group exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset, the Company will determine the fair value of the asset or asset group. The amount of impairment loss recognized is the excess of the asset or asset group’s carrying amount over its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported as assets held for sale at the lower of the carrying amount or the asset’s fair value less cost to sell and depreciation is ceased. Upon sale or other disposition of an asset, the Company recognizes a gain or loss on disposal measured as the difference between the net carrying amount of the asset and the net proceeds received. Leases The Company leases certain facilities, land, vehicles, and equipment. The Company determines if an arrangement is classified as a lease at inception of the arrangement. The Company recognizes a ROU asset and a lease liability at the lease commencement date. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the related lease. Finance leases are under the current and non-current liabilities and the underlying assets are included in property and equipment on the consolidated balance sheet. For operating and finance leases, the lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. As most of the Company’s leases do not provide an implicit rate of return, on a quarterly basis, the Company’s incremental borrowing rate is used, together with the lease term information available at commencement date of the lease, in determining the present value of lease payments. Operating lease liabilities include the noncancellable period of the lease plus related options to extend or terminate lease terms that are reasonably certain of being exercised. Lease payments included in the measurement of the lease liability comprise fixed payments owed over the lease term. Leases with an initial term of 12 months or less (“short term leases”) are not recorded on the balance sheet; and the lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company entered into a sublease for its former headquarters, which is being accounted for under lessor accounting. The nature of the sublease did not relieve the Company of its obligations under the original lease. The lease for the prior headquarters was an operating lease and, as such, the Company continues to account for the original lease as it did prior to entering the sublease. Since the former facility is not a component of the Company’s central operations, the income from the sublease and the expenses under the original lease are recorded in Other income, net on our Consolidated Statement of Operations. Convertible Notes Payable and Liability Classified Contract Consideration Convertible Notes Payable The Company accounted for the Convertible Notes Payable at amortized cost pursuant to Financial Accounting Standards Board (“FASB”) ASC Topic 470, Debt. The Company accounted for the Contract Consideration Convertible Notes Payable issued as consideration related to a related party contract (see Note 9, “Debt and Convertible Notes Payable”), as liability classified convertible instruments in accordance with FASB ASC 718, “Stock Compensation” (“ASC 718”). Under ASC 718, liability classified convertible instruments are measured at fair value at the grant date and at each reporting date (see Note 10, “Fair Value Measurements”) with the change in fair value included in the consolidated statements of operations. The Convertible Notes Payable and Contract Consideration Convertible Notes Payable were converted during 2023 through a series of transactions into the Company’s common stock. See Note 13, “Stockholders’ Equity” for additional information. Fair Value Measurements The Company categorizes financial assets and liabilities using a three-tier fair value hierarchy, based on the nature of the inputs used to determine fair value. Inputs refer broadly to assumptions that market participants would use to value an asset or liability and may be observable or unobservable. When determining the fair value of assets and liabilities, the Company uses the most reliable measurement available. See Note 10, “Fair Value Measurements.” Revenue Recognition The Company recognizes revenue when it satisfies performance obligations under the terms of the contract with a customer, and control of the promised goods are transferred to the customer or services are performed, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. The Company recognizes revenue based on a five-step model when all of the following criteria have been met: (i) a contract with a customer exists, (ii) performance obligations have been identified, (iii) the price to the customer has been determined, (iv) the price to the customer has been allocated to the performance obligations, and (v) performance obligations are satisfied. Products and services are sold with fixed or determinable prices. Variable consideration is estimated for the Contract Shortfall Fees from the ProFrac Agreement (see Note 16, “Related Party Transactions”) using the most likely amount and the Company includes an estimated amount of variable consideration in the transaction price only if it is probable that a subsequent change in the estimate of the amount of variable consideration would not result in a significant revenue reversal. A significant revenue reversal would occur if a subsequent change in the estimate of the variable consideration would result in a significant downward adjustment to the amount of cumulative revenue recognized from that contract when the change in estimate occurs. Certain sales include right of return provisions, which are considered when recognizing revenue and deferred accordingly, and discounts are offered to customers for prompt payment. The Company does not act as an agent in any of its revenue arrangements. In recognizing revenue for products and services, the Company determines the transaction price of contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services can be distinguished in the context of the contract. The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable included in accounts receivable, net and accounts receivable, related party on our Consolidated Balance Sheet. The majority of the CT segment revenue is chemical products that are sold at a point in time based on when control transfers to the customer determined by agreed upon delivery terms. Contracts with customers for the sale of products generally state the terms of the sale, including the quantity and price of each product purchased. Additionally, the CT segment offers various services associated to products sold, which includes field services, installation, maintenance, and other functions. These services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation when the Company has a right to invoice the customer. The DA segment recognizes revenue for sales of equipment at the time of sale based on when control transfers to the customer based on agreed upon delivery terms. Additionally, the Company offers various services associated with products sold, which includes field services, installation, maintenance, and other functions. Services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation. There may be additional performance obligations related to providing ongoing or reoccurring maintenance. Revenue for these types of arrangements is recognized ratably over time throughout the contract period. Additionally, the Company may provide subscription-type arrangements with customers in which monthly reoccurring revenue is recognized ratably over time in accordance with agreed upon terms and conditions. Customers may be invoiced for such maintenance and subscription-type arrangements, and revenue not yet recognizable is reported under accrued liabilities and deferred revenue on the consolidated balance sheets. Payment terms for both the CT and DA segments are customarily 30-60 days for domestic products or services and 60-90 days for international products and services from invoice receipt. Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Contract assets associated with incomplete performance obligations are not material. The Company applies several practical expedients including: •Sales commissions are expensed as selling, general and administrative expenses when incurred because the amortization period is generally one year or less. •The Company’s payment terms are short-term in nature with settlements of one year or less. As a result, the Company does not adjust the promised amount of consideration for the effects of a significant financing component. •In most service contracts, the Company has the right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company’s performance obligations completed to date and as such the Company recognizes revenue in the amount to which it has a right to invoice. •The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. Such taxes are included in accrued liabilities on our consolidated balance sheet until remitted to the governmental agency. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of sales in our consolidated statement of operations. Foreign Currency Translation The Company’s functional currency is primarily the U.S. dollar. The Company operates principally in the United States and substantially all assets and liabilities of the Company are denominated in U.S. dollars. Financial statements of foreign subsidiaries that are not U.S. dollar functional currency are prepared using the currency of the primary economic environment of the foreign subsidiaries as the functional currency. Assets and liabilities of those foreign subsidiaries are translated into U.S. dollars at exchange rates in effect as of the end of identified reporting periods. Revenue and expense transactions are translated using the average monthly exchange rate for the reporting period. Resultant translation adjustments are recognized as other comprehensive income (loss) within stockholders’ equity. Comprehensive Income Comprehensive income encompasses all changes in stockholders’ equity, except those arising from investments and distributions to stockholders. The Company’s comprehensive income loss includes consolidated net income (loss) and foreign currency translation adjustments. Research and Development Costs Expenditures for research activities relating to product development and improvement are charged to expense as incurred. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for temporary differences between financial statement carrying amounts and the tax bases of assets and liabilities and are measured using the tax rates expected to be in effect when the differences reverse. Deferred tax assets are also recognized for operating loss and tax credit carry forwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company’s policy is to record interest and penalties related to uncertain tax positions as income tax expense. Stock-Based Compensation Stock-based compensation expense, related to stock options, restricted stock awards and restricted stock units, is recognized based on their grant-date fair values. The Company recognizes compensation expense, net of estimated forfeitures, on a straight-line basis over the requisite service period of the award. Estimated forfeitures are based on historical experience. Stock Warrants The Company evaluated the Pre-Funded Warrants issued in February 2023 (the “February 2023 Warrants”) (see Note 13, “Stockholders’ Equity) in accordance with ASC 815-40, “Contracts in Entity’s Own Equity” and determined the February 2023 Warrants meet the criteria to be classified within stockholders’ equity. Accordingly, the Company reclassified the balance of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”) upon conversion for the February 2023 Warrants within additional paid in capital. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant items subject to estimates and assumptions include estimated variable consideration included in contract transaction price; the useful lives of property and equipment; long lived asset impairment assessments; stock-based compensation expense; allowance for credit losses for accounts receivable; valuation allowances for inventories and deferred tax assets; recoverability and timing of the realization of contract assets; and, in 2023, the fair value of liability classified Contract Consideration Convertible Notes Payable. Recent Accounting Pronouncements Changes to U.S. GAAP are established by the FASB. We evaluate the applicability and impact of all authoritative guidance issued by the FASB. Guidance not listed below was assessed and determined to be either not applicable, clarifications of items listed below, immaterial or already adopted by the Company. New Accounting Standards Issued and Not Adopted as of March 31, 2024 The FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”). The amendments under ASU 2023-09 were created as a response to requests from investors, lenders, creditors and other parties to enhance transparency and effectiveness of tax disclosures to help them better assess how an entity’s operations and related tax risks affect an entity’s tax rate and potential future cash flows. ASU 2023-09 requires that entities annually disclose the amount of taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions and that those amounts are also disaggregated by individual jurisdictions equal to or greater than 5% of total income taxes paid (net of funds received). ASU 2023-09 adds a requirement that entities disaggregate income (loss) from continuing operations before income tax expense (benefit) between domestic and foreign. The amendments also require entities to disaggregate income tax expense (benefit) by federal, state and foreign jurisdictions. The amendments under ASU 2023-09 also remove certain prior requirements. Public business entities are no longer required to disclose the nature and estimate of change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate cannot be determined. In addition public business entities are no longer required to disclose the cumulative amount of each type of temporary difference for which a deferred tax liability has not been recognized due to the exception to recognizing deferred taxes related to subsidiaries and corporate joint ventures. ASU 2023-09 goes into effect for annual periods beginning after December 15, 2024 and early adoption is permitted for annual financial statements not yet issued or made available for issuance. Adoption of the ASU is on a prospective basis, with the option to apply retrospectively. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures. The FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures.” This standard improves reportable segment disclosure requirements through enhanced disclosures around significant segment expenses. The amendments under this standard require interim and annual disclosures of significant segment expenses regularly provided to the chief operating decision maker (“CODM”). In addition, public entities are required to disclose the amount of “other segment items” by segment and their composition; make annual disclosures about a reportable segment’s profit/loss and assets; and clarify if the CODM uses more than one measure of a segment’s profit or loss in assessing performance and resource allocation and disclose the name and title of the CODM. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and the amendments are applied retrospectively to all prior periods presented. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures.

v3.24.1.u1

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Disaggregation of Revenue The Company differentiates revenue based on whether the source of revenue is attributable to product sales or service revenue. Total revenue disaggregated by revenue source is as follows (in thousands):   Three months ended March 31,   2024 2023 Revenue: Products (1) $ 39,106  $ 46,767  Services 1,268  1,240  $ 40,374  $ 48,007  (1) Product revenue includes sales to related parties as described in Note 16, “Related Party Transactions.” Disaggregation of Cost of Sales The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs which cannot be directly attributable to either tangible goods or services. Total cost of sales disaggregated is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Tangible goods sold $ 27,025  $ 41,529  Services 94  141  Other 4,434  4,457  $ 31,553  $ 46,127  Other cost of sales represent costs directly associated with the generation of revenue but which cannot be attributed directly to tangible goods sold or services. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs. Cost of sales split between external and related party sales is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Cost of sales for external customers $ 12,952  $ 11,196  Cost of sales for related parties 18,601  34,931  $ 31,553  $ 46,127  Contract Assets Contract assets are as follows (in thousands): March 31, 2024 December 31, 2023 Contract assets $ 83,060  $ 83,060  Less accumulated amortization (9,672) (8,405) Contract assets, net 73,388  74,655  Less current contract assets (7,019) (5,836) Contract assets, long term $ 66,369  $ 68,820  In connection with entering into the Initial ProFrac Agreement and Amended ProFrac Agreement on February 2, 2022 and May 17, 2022, respectively, as discussed in Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions,” the Company recognized contract assets of $10.0 million and $69.5 million, respectively, and associated fees of $3.6 million. As of March 31, 2024 and December 31, 2023, $66.4 million and $68.8 million, respectively, of the contract assets were classified as long term based upon our estimate of the forecasted revenues from the ProFrac Agreement which will not be realized within the next twelve months of the ProFrac Agreement. The Company’s estimate of the timing of the future contract revenues is evaluated on a quarterly basis. During the three months ended March 31, 2024 and 2023, the Company recognized $1.3 million and $1.3 million, respectively, of contract assets amortization which is recorded as a reduction of the transaction price included in the related party revenue in the consolidated statement of operations. The below table reflects our estimated amortization per year (in thousands) based on the Company’s current forecasted revenues from the ProFrac Agreement. Years ending December 31, Amortization 2024 (excluding the three months ended March 31, 2024) $ 5,029  2025 8,749  2026 9,538  2027 9,538  2028 9,538  Thereafter through May 2032 30,996  Total contract assets $ 73,388  Based on our tests of recoverability, we did not recognize any impairment of such contract assets as of March 31, 2024.

v3.24.1.u1

Contract Assets	3 Months Ended
	Mar. 31, 2024
Revenue Recognition [Abstract]
Contract Assets	Revenue from Contracts with Customers Disaggregation of Revenue The Company differentiates revenue based on whether the source of revenue is attributable to product sales or service revenue. Total revenue disaggregated by revenue source is as follows (in thousands):   Three months ended March 31,   2024 2023 Revenue: Products (1) $ 39,106  $ 46,767  Services 1,268  1,240  $ 40,374  $ 48,007  (1) Product revenue includes sales to related parties as described in Note 16, “Related Party Transactions.” Disaggregation of Cost of Sales The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs which cannot be directly attributable to either tangible goods or services. Total cost of sales disaggregated is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Tangible goods sold $ 27,025  $ 41,529  Services 94  141  Other 4,434  4,457  $ 31,553  $ 46,127  Other cost of sales represent costs directly associated with the generation of revenue but which cannot be attributed directly to tangible goods sold or services. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs. Cost of sales split between external and related party sales is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Cost of sales for external customers $ 12,952  $ 11,196  Cost of sales for related parties 18,601  34,931  $ 31,553  $ 46,127  Contract Assets Contract assets are as follows (in thousands): March 31, 2024 December 31, 2023 Contract assets $ 83,060  $ 83,060  Less accumulated amortization (9,672) (8,405) Contract assets, net 73,388  74,655  Less current contract assets (7,019) (5,836) Contract assets, long term $ 66,369  $ 68,820  In connection with entering into the Initial ProFrac Agreement and Amended ProFrac Agreement on February 2, 2022 and May 17, 2022, respectively, as discussed in Note 9, “Debt and Convertible Notes Payable” and Note 16, “Related Party Transactions,” the Company recognized contract assets of $10.0 million and $69.5 million, respectively, and associated fees of $3.6 million. As of March 31, 2024 and December 31, 2023, $66.4 million and $68.8 million, respectively, of the contract assets were classified as long term based upon our estimate of the forecasted revenues from the ProFrac Agreement which will not be realized within the next twelve months of the ProFrac Agreement. The Company’s estimate of the timing of the future contract revenues is evaluated on a quarterly basis. During the three months ended March 31, 2024 and 2023, the Company recognized $1.3 million and $1.3 million, respectively, of contract assets amortization which is recorded as a reduction of the transaction price included in the related party revenue in the consolidated statement of operations. The below table reflects our estimated amortization per year (in thousands) based on the Company’s current forecasted revenues from the ProFrac Agreement. Years ending December 31, Amortization 2024 (excluding the three months ended March 31, 2024) $ 5,029  2025 8,749  2026 9,538  2027 9,538  2028 9,538  Thereafter through May 2032 30,996  Total contract assets $ 73,388  Based on our tests of recoverability, we did not recognize any impairment of such contract assets as of March 31, 2024.

v3.24.1.u1

Inventories	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are as follows (in thousands): March 31, 2024 December 31, 2023 Raw materials $ 5,618  $ 5,299  Finished goods 14,281  13,660  Inventories 19,899  18,959  Less reserve for excess and obsolete inventory (6,028) (6,121) Inventories, net $ 13,871  $ 12,838  The additional reserves recorded during the three months ended March 31, 2024 and 2023 were $0.3 million and $0.1 million, respectively, for the CT segment and $13 thousand and $0.1 million, respectively, for the DA segment.

v3.24.1.u1

Property and Equipment	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment are as follows (in thousands): March 31, 2024 December 31, 2023 Land $ 886  $ 886  Land improvements 520  520  Buildings and leasehold improvements 5,487  5,483  Machinery and equipment 7,065  6,993  Furniture and fixtures 520  520  Transportation equipment 945  945  Computer equipment and software 1,772  1,696     Property and equipment 17,195  17,043  Less accumulated depreciation (12,134) (11,914) Property and equipment, net $ 5,061  $ 5,129  Depreciation expense totaled $0.2 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.u1

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	Leases The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2024 2023 Operating lease expense $ 784  $ 869  Finance lease expense: Amortization of assets 4  4  Interest on lease liabilities —  1  Total finance lease expense 4  5  Short-term lease expense 259  41  Total lease expense $ 1,047  $ 915  Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,654  $ 1,365  Operating cash flows from finance leases 13  10  Financing cash flows from finance leases —  1  Maturities of lease liabilities as of March 31, 2024 are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2024 (excluding the three months ended March 31, 2024) $ 2,073  $ 13  2025 2,046  —  2026 1,732  —  2027 1,660  —  2028 1,518  —  Thereafter 2,815  —  Total lease payments $ 11,844  $ 13  Less: Interest (2,640) —  Present value of lease liabilities $ 9,204  $ 13  Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2024 December 31, 2023 Operating Leases Operating lease right-of-use assets $ 4,336  $ 5,030  Current portion of operating lease liabilities 2,083  2,449  Long-term operating lease liabilities 7,121  7,676  Total operating lease liabilities $ 9,204  $ 10,125  Finance Leases Property and equipment $ 147  $ 147  Accumulated depreciation (74) (70) Property and equipment, net $ 73  $ 77  Current portion of finance lease liabilities $ 13  $ 22  Long-term finance lease liabilities —  —  Total finance lease liabilities $ 13  $ 22  Weighted Average Remaining Lease Term Operating leases 5.6 years 5.5 years Finance leases 0.3 years 0.6 years Weighted Average Discount Rate Operating leases 9.4  % 9.5  % Finance leases 8.5  % 8.5  % Sublease Income On April 1, 2023, the Company entered into an agreement to sublease its office and lab space in Houston, Texas beginning September 1, 2023 and continuing until October 30, 2030. The rental income from the sublease is included in the Company’s statement of operations in Other income (expense), net, and offsets the monthly rental expense of $86 thousand from the Company’s lease of the facility from the landlord. Sublease rental income for future years are as follows (in thousands): Years ending December 31, Rental Income 2024 (excluding the three months ended March 31, 2024) $ 575  2025 767  2026 767  2027 767  2028 767  Thereafter 1,406  Total rental income $ 5,049
Leases	Leases The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2024 2023 Operating lease expense $ 784  $ 869  Finance lease expense: Amortization of assets 4  4  Interest on lease liabilities —  1  Total finance lease expense 4  5  Short-term lease expense 259  41  Total lease expense $ 1,047  $ 915  Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,654  $ 1,365  Operating cash flows from finance leases 13  10  Financing cash flows from finance leases —  1  Maturities of lease liabilities as of March 31, 2024 are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2024 (excluding the three months ended March 31, 2024) $ 2,073  $ 13  2025 2,046  —  2026 1,732  —  2027 1,660  —  2028 1,518  —  Thereafter 2,815  —  Total lease payments $ 11,844  $ 13  Less: Interest (2,640) —  Present value of lease liabilities $ 9,204  $ 13  Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2024 December 31, 2023 Operating Leases Operating lease right-of-use assets $ 4,336  $ 5,030  Current portion of operating lease liabilities 2,083  2,449  Long-term operating lease liabilities 7,121  7,676  Total operating lease liabilities $ 9,204  $ 10,125  Finance Leases Property and equipment $ 147  $ 147  Accumulated depreciation (74) (70) Property and equipment, net $ 73  $ 77  Current portion of finance lease liabilities $ 13  $ 22  Long-term finance lease liabilities —  —  Total finance lease liabilities $ 13  $ 22  Weighted Average Remaining Lease Term Operating leases 5.6 years 5.5 years Finance leases 0.3 years 0.6 years Weighted Average Discount Rate Operating leases 9.4  % 9.5  % Finance leases 8.5  % 8.5  % Sublease Income On April 1, 2023, the Company entered into an agreement to sublease its office and lab space in Houston, Texas beginning September 1, 2023 and continuing until October 30, 2030. The rental income from the sublease is included in the Company’s statement of operations in Other income (expense), net, and offsets the monthly rental expense of $86 thousand from the Company’s lease of the facility from the landlord. Sublease rental income for future years are as follows (in thousands): Years ending December 31, Rental Income 2024 (excluding the three months ended March 31, 2024) $ 575  2025 767  2026 767  2027 767  2028 767  Thereafter 1,406  Total rental income $ 5,049

v3.24.1.u1

Accrued Liabilities	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities Current accrued liabilities are as follows (in thousands):   March 31, 2024 December 31, 2023 Severance costs $ 417  $ 648  Payroll and benefits 937  2,138  Legal costs 201  37  Contingent liability for earn-out provision 30  56  Deferred revenue, current 303  550  Taxes other than income taxes 182  656  Other 1,295  1,805  Total current accrued liabilities $ 3,365  $ 5,890

v3.24.1.u1

Debt and Convertible Notes Payable	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt and Convertible Notes Payable	Debt and Convertible Notes Payable Asset Based Loan On August 14, 2023, the Company entered into a 24-month revolving loan and security agreement in connection with an asset-based loan (the “ABL”). The ABL is classified, under ASC 470, as current debt on our consolidated balance sheet due to the nature of the payment arrangements where the lender is paid from customer payments received into the Company’s collections account. The ABL provides up to $13.8 million of credit availability, which is limited by a borrowing base consisting of (i) 85% of eligible accounts receivable, plus (ii) 60% of the value of eligible inventory not to exceed 100% of the eligible accounts receivable. As of March 31, 2024, the Company had $3.1 million outstanding with approximately $6.0 million of available borrowings under the ABL. During the three months ended March 31, 2024, the Company incurred $0.2 million in interest and fees related to the ABL. As of March 31, 2024, the Company recorded $0.1 million of amortized deferred financing costs related to the ABL. Borrowings under the ABL bear interest at the Wall Street Journal Prime Rate (subject to a floor of 5.5%) plus 2.5% per annum. The interest rate under the ABL was 11.0% as of March 31, 2024. The ABL contains an annual commitment fee equal to 1.0% of the ABL’s borrowing base. Additionally, the Company will be assessed a non-usage fee of 0.25% per quarter based on the difference between the average daily outstanding balance and the borrowing base limit of the ABL. If the ABL is terminated prior to the end of its 24-month term, the Company is required to pay an early termination fee of 2.50% of the borrowing base limit of the ABL (if terminated with more than 12 months remaining until the maturity date) or 1.50% of the borrowing base limit of the ABL (if terminated with less than 12 months remaining until the maturity date). The ABL contains customary representations, warranties, covenants and events of default, the occurrence of which would permit the lender to accelerate the payment of any amounts borrowed. The ABL requires the Company to maintain a minimum Tangible Net Worth (as defined in the ABL) of not less than $11 million. In addition, the ABL provides the lender a blanket security interest on all or substantially all of the Company’s assets. The Company was in compliance with all of the covenants under the ABL as of March 31, 2024. Paycheck Protection Program Loan In April 2020, the Company received a $4.8 million loan (the “Flotek PPP loan”) under the Paycheck Protection Program (“PPP”), which was created through the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). In October 2021, the Flotek PPP loan maturity date was extended from April 15, 2022 to April 15, 2025. On January 5, 2023, the Company received notice from the SBA that $4.4 million of the $4.8 million principal amount and accrued interest to that date of $0.1 million were forgiven. The remaining principal amount of $0.4 million and accrued interest is to be repaid in monthly installments of $15 thousand over the remaining term of the loan through April 15, 2025, beginning on March 15, 2023. The forgiveness of the Flotek PPP loan is accounted for as an extinguishment of the debt and the Company recorded a $4.5 million gain in the three months ended March 31, 2023, comprising the principal amount forgiven of $4.4 million and accrued interest of $0.1 million. Long-term debt, including current portion, is as follows (in thousands): March 31, 2024 December 31, 2023 Flotek PPP loan $ 194  $ 239  Less current maturities (179) (179) Total long-term debt, net of current portion $ 15  $ 60  Loan repayments are scheduled as follows (in thousands): Years ending December 31, Repayment 2024 (excluding the three months ended March 31, 2024) $ 134  2025 60  Total Flotek PPP loan $ 194  Convertible Notes Payable On February 2, 2022, Flotek entered into a Private Investment in Public Equity transaction (the “PIPE transaction”) with a consortium of investors to secure growth capital for the Company. Pursuant to the PIPE transaction, Flotek issued $21.2 million in aggregate initial principal amount of Convertible Notes Payable for net cash proceeds of approximately $20.1 million (the “Convertible Notes Payable”). The investors were ProFrac Holdings, LLC, Burlington Ventures Ltd., entities associated with North Sound Management, certain funds associated with one of Flotek's directors including the D3 Family Fund and the D3 Bulldog Fund, and Firestorm Capital LLC. The Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum, had a maturity of one year, and were convertible into common stock of Flotek or Pre-Funded Warrants to purchase common stock of Flotek, (a) at the holder's option at any time prior to maturity, at a price of $1.088125 per share on a pre-Reverse Stock Split basis, (b) at Flotek's option, if the volume-weighted average trading price of Flotek's common stock equals or exceeds $2.50 per share on a pre-Reverse Stock Split basis, or $1.741 per share on a pre-Reverse Stock Split basis, for 20 trading days during a 30 consecutive trading day period, or (c) at maturity, at a price of $0.8705 per share on a pre-Reverse Stock Split basis. On March 21, 2022, a portion of of the Convertible Notes Payable, plus accrued paid-in-kind interest thereon, were converted at the holder’s option into shares of common stock. The issuance cost was amortized on a straight-line basis over the term of the Convertible Notes Payable and the amortization was included in interest expense in the unaudited condensed consolidated statements of operations. The carrying value was recorded as additional paid in capital. Upon maturity on February 2, 2023, the Convertible Notes Payable, excluding those held by ProFrac Holdings, LLC, with a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million, were converted on a pre-Reverse Stock Split basis into 10,335,840 shares of common stock (1,722,640 shares of the Company’s common stock on a post-Reverse Stock Split basis) at a price of $0.8705 per share. The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share and were recorded as additional paid in capital upon conversion. Initial ProFrac Agreement Contract Consideration Convertible Notes Payable On February 2, 2022, the Company entered into a long-term supply agreement with ProFrac Services, LLC (the “Initial ProFrac Agreement”), a subsidiary of ProFrac Holdings LLC, in exchange for $10 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Initial ProFrac Agreement Contract Consideration Convertible Notes Payable”), under the same terms as the Convertible Notes Payable issued in the PIPE transaction described above, including paid-in-kind interest at a rate of 10% per annum and conversion features. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $10.0 million on the issuance date with a corresponding contract asset. On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, remeasured to and carried at a fair value of $15.1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants with an exercise price of $0.0001 per share (see Note 10, “Fair Value Measurements”) and were recorded as additional paid in capital upon conversion. Amended ProFrac Agreement Contract Consideration Convertible Notes Payable On May 17, 2022, the Company entered into an amendment to the Initial ProFrac Agreement (the “Amended ProFrac Agreement” and collectively with the Initial ProFrac Agreement, the “ProFrac Agreement”) upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (“Amended ProFrac Agreement Contract Consideration Convertible Notes Payable”) to ProFrac. The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable accrued paid-in-kind interest at a rate of 10% per annum. The Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were accounted for as liability classified convertible instruments and were initially recorded at fair value of $69.5 million on the issuance date with a corresponding contract asset. On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, remeasured to and carried at a fair value of $40.6 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (see Note 10, “Fair Value Measurements”). As a result of the Reverse Stock Split, these shares were converted into 10,582,821 common shares.

v3.24.1.u1

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. •Level 1 — Quoted prices in active markets for identical assets or liabilities; •Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and •Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs. Fair Value of Other Financial Instruments The carrying amounts of certain financial instruments, including cash and cash equivalents, restricted cash, accounts receivable, accrued liabilities, accounts payable and ABL approximate fair value due to the short-term nature of these accounts. Liabilities Measured at Fair Value on a Recurring Basis The following table presents the Company’s liabilities that are measured at fair value on a recurring basis and the level within the fair value hierarchy (in thousands): March 31, December 31, Level 1 Level 2 Level 3 2024 Level 1 Level 2 Level 3 2023 Contingent earnout consideration $ —  $ —  $ 30  $ 30  $ —  $ —  $ 56  $ 56  Total $ —  $ —  $ 30  $ 30  $ —  $ —  $ 56  $ 56  Contingent Earnout Consideration Key Inputs The estimated fair value of the remaining stock performance earn-out provision, with respect to the JP3 transaction, is included in accrued liabilities as of March 31, 2024 and December 31, 2023. The estimated fair value of the earn-out provision at the end of each period was valued using a Monte Carlo model analyzing 20,000 simulations performed using Geometric Brownian Motion with inputs such as risk-neutral expected growth and volatility. March 31, 2024 December 31, 2023 Risk-free interest rate 4.97  % 4.58  % Expected volatility 70.0  % 70.0  % Term until liquidation (years) 1.13  1.38  Stock price (pre-Reverse Stock Split basis) $ 3.74  $ 3.92  Discount rate 13.67  % 11.86  % Initial ProFrac Agreement Contract Consideration Notes Payable Key Inputs The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were measured at fair value at issuance and on a recurring basis. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable had an initial fair value of $10.0 million on February 2, 2022. The Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were classified as Level 2 at the initial measurement upon issuance due to the use of a quoted price for a similar liability at that date (the PIPE transaction), and subsequently classified as Level 3 due to the use of unobservable inputs. On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, upon maturity, to a fair value of $15.1 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $1.19, on the date of conversion. The fair value adjustment was a $0.8 million increase for the three months ended March 31, 2023. Amended ProFrac Agreement Contract Consideration Convertible Notes Payable Key Inputs On May 17, 2022, the Company measured the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable classified as Level 3 using a Monte Carlo simulation at an estimated fair value of $69.5 million. The Company reduced the discount rate assumed due to the reduced likelihood of occurrence of any of the default events in the shorter term remaining on the notes. The estimated value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable as of March 31, 2023 was remeasured using a Monte Carlo simulation resulting in a gain in fair value of Contract Consideration Convertible Notes Payable of $26.9 million for the three months ended March 31, 2023. On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were remeasured, at maturity, to a fair value of $40.6 million based on the pre-Reverse Stock Split closing price of the shares of common stock of $0.64, on the date of conversion. Assets Measured at Fair Value on a Nonrecurring Basis The Company’s non-financial assets, including property and equipment and operating lease ROU assets, are measured at fair value on a non-recurring basis and are subject to adjustment to their fair value in certain circumstances. Level 3 Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents the changes in balances of liabilities for the three months ended March 31, 2024 and 2023 classified as Level 3 (in thousands): Three months ended March 31, 2024 2023 Balance - beginning of period $ 56  $ 84,153  Increase in principal of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest —  85  Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest —  1,331  Change in fair value of contingent earnout consideration (26) (358) Change in fair value of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable —  786  Change in fair value of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable —  (26,881) Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity —  (15,092) Balance - end of period $ 30  $ 44,024

v3.24.1.u1

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21% to income (loss) before income tax for the reasons set forth below: Three months ended March 31, 2024 2023 U.S. federal statutory tax rate 21.0  % 21.0  % State income taxes, net of federal benefit 13.5  —  Non-U.S. income taxed at different rates (5.2) 0.1  Increase (reduction) in tax benefit related to stock-based awards 1.2  0.4  Change in valuation allowance (18.8) (20.5) Permanent differences related to CARES Act —  (1.1) Non-deductible expenses 1.8  0.1  Effective income tax rate 13.5  % —  % As of March 31, 2024, the Company had U.S. net operating loss carryforwards (“NOLs”) of $194.8 million, including $46.4 million expiring in various amounts from 2029 through 2037 which can offset 100% of taxable income and $148.4 million that has an indefinite carryforward period which can offset 80% of taxable income per year. Additionally, the Company has an estimated $96.1 million in certain state NOL carryforwards, $0.7 million in Section 163(j) interest limitation carryforwards and $3.8 million in tax credit carryforwards. As a result of the ownership change experienced in 2023, the Company’s ability to use NOLs to reduce taxable income is generally limited by Section 382 of the Internal Revenue Code of 1986 to an annual amount of $3.5 million plus an uplift of $24.5 million. NOLs that exceed the Section 382 limitation in any year continue to be allowed as carryforwards until they expire and can be used to offset taxable income for years within the carryover period subject to the limitation in each year. The Company’s use of NOLs arising after the date of the ownership change are not impacted by the Section 382 limitation. If the Company does not generate a sufficient level of taxable income prior to the expiration of the pre-2018 NOL carryforward periods, then the ability to apply those NOLs as offsets to future taxable income is lost. Based on an analysis of the Section 382 limitation, the Company estimates that $31.3 million of the state NOL carryforwards (subject to additional state-by-state analysis) and $3.8 million of the tax credit carryforwards will expire unutilized. Although the ownership change will significantly limit the ability of the Company to utilize the pre-change net operating losses and credits, the Company does not expect a significant impact to its financial statements given the valuation allowance that is recorded to estimate the realizability of the deferred tax assets.

v3.24.1.u1

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity. Other Commitments and Contingencies The Company is subject to concentrations of credit risk within trade accounts receivable, and related party accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in three major U.S. financial institutions and balances often exceed insurable amounts.

v3.24.1.u1

Stockholders’ Equity	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Reverse stock split On September 14, 2023, the Company announced that the Board of Directors approved a reverse stock split of its common stock at a ratio of 1-to-6 (“Reverse Stock Split”). The Reverse Stock Split was completed on September 25, 2023 and resulted in 184,438,695 issued and outstanding shares of common stock being converted into 30,772,837 shares of common stock. The Reverse Stock Split had no effect on the par value or on the number of authorized shares of common stock. The Company issued one whole share of common stock to any shareholder that would have received a fractional share as a result of the Reverse Stock Split. Therefore, no fractional shares were issued in connection with the Reverse Stock Split and no cash or other consideration was paid in connection with any fractional shares that resulted from the Reverse Stock Split. The Company adjusted the number of outstanding shares of common stock and treasury stock on the consolidated balance sheet and in the statement of changes in stockholders’ equity for all periods presented to reflect the impacts of the Reverse Stock Split. Where we disclose the number of shares of common stock within the footnotes to the consolidated financial statements we have presented both the pre-Reverse Stock Split and post-Reverse Stock Split amount as denoted. Unless otherwise noted, all references in the consolidated financial statements and notes to condensed consolidated financial statements to the number of shares, per share data, restricted stock and stock option data have been retroactively adjusted to give effect to the Reverse Stock Split. Conversion of Convertible Notes Payable On February 2, 2023, the Convertible Notes Payable pursuant to the PIPE transaction discussed in Note 9, “Debt and Convertible Notes Payable”, excluding those held by ProFrac Holdings, LLC, were converted on a pre-Reverse Stock Split basis, upon maturity, into 10,335,840 shares of common stock (1,722,640 shares of common stock on a post-Reverse Stock Split basis) at a price of $0.8705 per share. The Convertible Notes Payable converted into common stock shares had a carrying value of $9.0 million, including accrued paid-in-kind interest of $0.8 million and were recorded as additional paid-in-capital upon conversion. The Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants with an exercise price of $0.0001 per share and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Convertible Notes Payable held by ProFrac Holding, LLC were exercised and the Company issued, on a pre-Reverse Stock Split basis, 12,683,280 shares of the Company’s common stock (2,113,880 shares of the Company’s common stock on a post-Reverse Stock Split basis). On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable”, remeasured to a fair value of $15.1 million upon maturity, were converted on a pre-Reverse Stock Split basis, into 12,683,281 February 2023 Warrants and were recorded as additional paid-in-capital upon conversion. On September 6, 2023, the February 2023 Warrants issued upon the conversion of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable were exercised and the Company issued on a pre-Reverse Stock Split basis, 12,683,281 shares of the Company’s common stock (2,113,881 shares of the Company’s common stock on a post-Reverse Stock Split basis). On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable discussed in Note 9, “Debt and Convertible Notes Payable” were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (10,582,821 shares of common stock on a post-Reverse Stock Split basis). The Contract Consideration Convertible Notes Payable converted into common stock shares, remeasured to a fair value of $40.6 million upon maturity, were recorded as additional paid-in-capital. Pre-Funded Warrants On June 21, 2022, ProFrac Holdings II, LLC paid $19.5 million for Pre-Funded Warrants (the “June 2022 Warrants”) of the Company. The June 2022 Warrants permit ProFrac Holdings II, LLC to purchase on a pre-Reverse Stock Split basis 13,104,839 shares of common stock of the Company (2,184,140 shares of the Company’s common stock on a post-Reverse Stock Split basis) at an exercise price equal to $0.0001 per share, subject to a $4.5 million exercise fee. ProFrac Holdings II, LLC and its affiliates may not receive any voting or consent rights in respect of the June 2022 Warrants or the underlying shares of common stock unless and until ProFrac Holdings II, LLC has paid an additional $4.5 million to the Company; provided, however, that ProFrac Holdings II may exercise the June 2022 Warrants immediately prior to the sale of the shares of common stock subject to such exercise to a non-affiliate of ProFrac Holdings II. The additional $4.5 million will be accounted for as an equity contribution if received.

v3.24.1.u1

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period, which includes the February 2023 Warrants (See Note 9, “Debt and Convertible Notes Payable”, and Note 13, “Stockholders’ Equity”). Diluted earnings (loss) per common share is calculated by dividing the adjusted net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive common share equivalents consist of incremental shares of common stock issuable upon conversion of convertible notes payable, exercise of stock warrants and vesting and settlement of stock awards. The dilutive effect of non-vested stock issued under share‑based compensation plans, shares issuable under the Employee Stock Purchase Plan (ESPP), employee stock options outstanding, and the Pre-Funded stock warrants are computed using the treasury stock method. The dilutive effect of the Convertible Notes is computed using the if‑converted method. For all periods presented in the table below, weighted average shares and earnings (loss) per share reflect the effects of the Reverse Stock Split. The calculation of the basic and diluted earnings (loss) per share for the three months ended March 31, 2024 and 2023 is as follows (in thousands):   Three months ended March 31,   2024 2023 Numerator: Net income for basic earnings per share $ 1,562  $ 21,343  Adjustments to net income available to shareholders Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable —  1,571  Valuation gain on Contract Consideration Convertible Notes Payable carried at fair value —  (26,095) Adjusted net income (loss) for diluted earnings per share $ 1,562  $ (3,181) Denominator: Basic weighted average shares outstanding 29,431  16,468  Dilutive effect of convertible notes payable —  9,994  Dilutive effect of warrants outstanding 779  —  Dilutive effect of stock options and restricted shares 106  —  Diluted weighted average shares outstanding 30,316  26,462  Basic earnings per share $ 0.05  $ 1.30  Diluted earnings (loss) per share $ 0.05  $ (0.12) Anti-dilutive incremental shares excluded from denominator for diluted earnings computation Average number of diluted shares for June 2022 stock warrants (1) —  1,500  Average number of diluted shares for options and restricted stock (1) —  170  (1) These items were not included in the dilution calculation for the three months ended March 31, 2023 due to their anti-dilutive effect as it would reduce the loss per share.

v3.24.1.u1

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information Supplemental cash flow information is as follows (in thousands):            Three months ended March 31,   2024 2023 Supplemental cash flow information: Interest paid $ 210  $ 18  Supplemental non cash financing and investing activities: Conversion of convertible notes payable to common stock —  8,996  Conversion of convertible notes payable to February 2023 Warrants —  11,040  Conversion of Initial Contract Consideration Convertible Notes Payable to February 2023 Warrants —  15,092

v3.24.1.u1

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions On February 2, 2022, the Company entered into the Initial ProFrac Agreement, upon issuance of $10 million in aggregate principal amount of the convertible notes (the “Contract Consideration Convertible Notes Payable”) to ProFrac Holdings LLC (see Note 9, “Debt and Convertible Notes Payable”). Under the Initial ProFrac Agreement, ProFrac Services, LLC is obligated to order chemicals from the Company at least equal to the greater of (a) the chemicals required for 33% of ProFrac Services, LLC’s hydraulic fracturing fleets and (b) a baseline measured by the first ten hydraulic fracturing fleets deployed by ProFrac Services, LLC during the term of the Initial ProFrac Agreement. If the minimum volumes are not achieved in any given year, ProFrac Services LLC shall pay to the Company, as liquidated damages an amount equal to twenty-five percent (25%) of the difference between (i) the aggregate purchase price of the quantity of products comprising the minimum purchase obligation and (ii) the actual purchased volume during such calendar year (“Contract Shortfall Fees”). On May 17, 2022, the Company entered into the Amended ProFrac Agreement upon issuance of $50 million in aggregate principal amount of Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”). The Initial ProFrac Agreement was amended to (a) increase ProFrac Services LLC’s minimum purchase obligation for each year to the greater of 70% of ProFrac Services LLC’s requirements and a baseline measured by ProFrac Services, LLC’s first 30 hydraulic fracturing fleets, and (b) increase the term to 10 years. On February 2, 2023, the Company entered into an amendment to the ProFrac Agreement (the “Amended ProFrac Agreement No. 2”). The Amended ProFrac Agreement No. 2 has an effective date of January 1, 2023. The ProFrac Agreement was amended to (1) provide a ramp-up period from January 1, 2023 to May 31, 2023 for ProFrac Services, LLC to increase the number of active hydraulic fracturing fleets to 30 fleets, (2) waive any Contract Shortfall Fee payment relating to any potential order shortfall prior to January 1, 2023, (3) add additional fees to certain products, and (4) provide margin increases based on margins with non-ProFrac customers. The current measurement period for Contract Shortfall Fees is January 1, 2024 through December 31, 2024. The Company does not expect that the minimum purchase requirements will be met during the current measurement period, and as a result, the revenues for three months ended March 31, 2024 reflect variable consideration for Contract Shortfall Fees of $8.7 million, which will be due in the first quarter of 2025 under the terms of the ProFrac Agreement. Because the measurement period for 2023 was June 1, 2023 through December 31, 2023, there are no Contract Shortfall Fees reflected in revenues for the first quarter of 2023. On February 2, 2023, the Convertible Notes Payable held by ProFrac Holding, LLC, with a carrying value of $11.0 million, including accrued paid-in-kind interest of $1.0 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,280 February 2023 Warrants (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”) and subsequently exercised on September 6, 2023. On February 2, 2023, the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, with a carrying value of $11.0 million, including accrued interest of $1 million, were converted on a pre-Reverse Stock Split basis, upon maturity, into 12,683,281 February 2023 Warrants and subsequently exercised on September 6, 2023 (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable, as of February 2, 2023, was $15.1 million (see Note 10, “Fair Value Measurements”). On May 17, 2023, the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable were converted on a pre-Reverse Stock Split basis, upon maturity, into 63,496,922 shares of common stock at a price of $0.8705 per share (see Note 9, “Debt and Convertible Notes Payable” and Note 13, “Stockholders’ Equity”). The fair value of the Amended ProFrac Agreement Contract Consideration Convertible Notes Payable, as of May 17, 2023 was $40.6 million (see Note 10, “Fair Value Measurements”). As a result of the Reverse Stock Split, these shares were converted into 10,582,821 common shares. During the three months ended March 31, 2024 and 2023, the Company’s revenues from ProFrac Services, LLC were $27.2 million and $36.4 million, respectively. For the three months ended March 31, 2024 and 2023, these revenues were net of amortization of contract assets of $1.3 million and $1.3 million, respectively. Cost of sales attributable to these revenues were $18.6 million and $34.9 million, respectively for the three months ended March 31, 2024 and 2023. As of March 31, 2024 and December 31, 2023 our accounts receivable from ProFrac Services, LLC was $38.7 million and $34.6 million, respectively which is recorded in accounts receivable, related party on the consolidated balance sheet. During the three months ended March 31, 2024, the Company collected $15.1 million of variable consideration of the $20.1 million related to the 2023 Contract Shortfall Fees which were included in accounts receivable, related party as of December 31, 2023. The remaining total of $5.0 million was collected subsequent to March 31, 2024.

v3.24.1.u1

Business Segment, Geographic and Major Customer Information	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Business Segment, Geographic and Major Customer Information	Business Segment, Geographic and Major Customer Information Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the chief operating decision-maker in deciding how to allocate resources and assess performance. The operations of the Company are categorized into the following reportable segments: Chemistry Technologies. The CT segment includes green specialty chemistries, logistics and technology services, which enable its customers to pursue improved efficiencies and performance throughout the life cycle of their wells, and also helping customers improve their ESG and operational goals. Customers of the CT segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. Data Analytics. The DA segment includes the design, development, production, sale and support of equipment and services that create and provide valuable information on the composition and properties of energy customers’ hydrocarbon fluids. The company markets products and services that support in-line data analysis of hydrocarbon components and properties. Customers of the DA segment span across the entire oil and gas market, from upstream production to midstream facilities to refineries and distribution networks. Performance is based upon a variety of criteria. The primary financial measure is segment operating income (loss). Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segments. Summarized financial information of the reportable segments is as follows (in thousands): As of and for the three months ended March 31, Chemistry Technologies Data Analytics Corporate and Other Total 2024 Revenue from external customers Products $ 11,159  $ 933  $ —  $ 12,092  Services 526  562  —  1,088  Total revenue from external customers 11,685  1,495  —  13,180  Revenue from related party Products 27,014  —  —  27,014  Services —  180  —  180  Total revenue from related parties 27,014  180  —  27,194  Gross profit 8,401  420  —  8,821  Income (loss) from operations 6,106  (424) (3,574) 2,108  Depreciation 159  35  26  220  Interest on ABL —  —  181  181  Other interest —  —  97  97  Income tax —  —  242  242  Additions to long-lived assets 147  —  5  152  2023 Revenue from external customers Products $ 8,561  $ 1,941  $ —  $ 10,502  Services 664  486  —  1,150  Total revenue from external customers 9,225  2,427  —  11,652  Revenue from related party Products 36,265  —  —  36,265  Services —  90  90  Total revenue from related parties 36,265  90  —  36,355  Gross profit 434  1,446  —  1,880  Change in fair value of Contract Consideration Convertible Notes Payable (26,095) —  —  (26,095) Income (loss) from operations 23,379  457  (5,325) 18,511  Paid-in-kind interest on Contract Consideration Convertible Notes Payable 1,416  —  —  1,416  Paid-in-kind interest on convertible notes payable —  —  155  155  Depreciation 157  18  1  176  Income tax —  —  9  9  Additions to long-lived assets 30  95  32  157  Assets of the Company by reportable segments are as follows (in thousands): March 31, 2024 December 31, 2023 Chemistry Technologies $ 139,551  $ 138,559  Data Analytics 6,253  6,604  Corporate and Other 10,046  12,350  Total assets $ 155,850  $ 157,513  Geographic Information Revenue by country is based on the location where services are provided and products are sold. For the three months ended March 31, 2024 and 2023 no individual countries other than the U.S. accounted for more than 10% of revenue. Revenue by geographic location is as follows (in thousands):   Three months ended March 31,   2024 2023 U.S. (1) $ 39,259  $ 46,126  UAE 741  1,403  Other countries 374  478  Total revenue $ 40,374  $ 48,007  (1) Includes revenue from related party Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements. Major Customers Revenue from major customers, as a percentage of consolidated revenue, is as follows (in thousands): Revenue % of Total Revenue Three months ended March 31, 2024 Customer A (Related Party) $ 27,194  67.4  % Three months ended March 31, 2023 Customer A (Related Party) $ 36,355  75.7  % The concentration with ProFrac Services, LLC and in the oil and gas industry increases credit, commodity and business risk. Major Suppliers Expenditure with major suppliers, as a percentage of consolidated supplier expenditure, is as follows (in thousands): Three months ended March 31, Expenditure % of Total Expenditure 2024 Supplier A $ 7,747  29.7  % Supplier B 5,020  19.2  % 2023 Supplier A $ 16,954  40.1  % Supplier B 7,145  16.9  % Supplier C 4,504  10.6  %

v3.24.1.u1

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events We have evaluated the effects of events that have occurred subsequent to March 31, 2024 through May 9, 2024, and there have been no material events that would require recognition in the March 31, 2024 interim financial statements or disclosure in the notes to the unaudited condensed consolidated financial statements.

v3.24.1.u1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements reflect all adjustments, in the opinion of management, necessary for the fair statement of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The financial statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the SEC regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s 2023 Annual Report.
Consolidation	All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries.
Cash Equivalents	Cash Equivalents Cash equivalents consist of highly liquid investments with maturities of three months or less at the date of purchase.
Restricted Cash	Restricted Cash The Company’s restricted cash was $0.1 million and $0.1 million as of March 31, 2024 and December 31, 2023, respectively. The Company’s restricted cash consists of cash that the Company is contractually obligated to maintain in accordance with the terms of its credit card program with a financial institution.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses Accounts receivable and accounts receivable, related party, arise from product sales and services and are stated at estimated net realizable value. This value incorporates an allowance for credit losses to reflect any loss anticipated on accounts receivable balances. The Company applies the current expected credit loss (CECL) model, which requires immediate recognition of expected credit losses over the contractual life of receivables and records the appropriate allowance for credit losses as a charge to Operating Cost and Expenses. The allowance for credit losses is based on a combination of the individual customer circumstances, credit conditions, and historical write-offs and collections. The Company writes off specific accounts receivable when they are determined to be uncollectible. The recovery of accounts receivable previously written off is recorded as a reduction to the allowance for credit losses charged to operating expense. The majority of the Company’s customers are engaged in the energy industry. The cyclical nature of the energy industry may affect customers’ operating performance and cash flows, which directly impact the Company’s ability to collect on outstanding obligations. Additionally, certain customers are located in international areas that are inherently subject to risks of economic, political, and civil instability, which can impact the collectability of receivables.
Contract Assets	Contract Assets The Company’s contract assets represent consideration issued in the form of convertible notes (Contract Consideration Convertible Notes Payable as discussed in Note 9, “Debt and Convertible Notes Payable”) and other incremental costs related to obtaining the ProFrac Agreement (see Note 16, “Related Party Transactions”). The contract assets are amortized over the term of the ProFrac Agreement (originally 10 years) based on forecasted revenues as goods are transferred to ProFrac Services, LLC, and the amortization is presented as a reduction of the transaction price included in related party revenue in the consolidated statements of operations. The contract assets are tested for recoverability on a recurring basis and the Company will recognize an impairment loss to the extent that the carrying amount of the contract assets exceeds the amount of consideration the Company expects to receive in the future for the transfer of goods under the ProFrac Agreement less the direct costs that relate to providing those goods in the future.
Inventories	Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost determined by using the weighted-average cost method, or net realizable value. Finished goods inventories include raw materials, direct labor and production overhead. The Company periodically reviews inventories on hand and current market conditions to determine if the cost of raw materials and finished goods inventories exceed current market prices and impairs the cost basis of the inventory accordingly. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its net realizable value if those amounts are determined to be less than cost. Write-downs or write-offs of inventory are charged to cost of sales.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Plant and equipment under finance leases are stated at the present value of the lease payments. The Company capitalizes costs associated with the acquisition of major software for internal use. The cost of ordinary maintenance and repair is charged to operating expense, while replacement of critical components and major improvements are capitalized. Depreciation or amortization of property and equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows: Buildings and leasehold improvements 2-30 years Machinery and equipment 7-10 years Furniture and fixtures 3 years Land improvements 20 years Transportation equipment 2-5 years Computer equipment and software 3-7 years Property and equipment, including ROU assets, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable. If events or changes in circumstances indicate the carrying amount of an asset or asset group may not be recoverable, the Company first compares the carrying amount of an asset or asset group to the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset. If the carrying amount of an asset or asset group exceeds the sum of the undiscounted future cash flows expected to result from the use and eventual disposal of the asset, the Company will determine the fair value of the asset or asset group. The amount of impairment loss recognized is the excess of the asset or asset group’s carrying amount over its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary.
Leases	Leases The Company leases certain facilities, land, vehicles, and equipment. The Company determines if an arrangement is classified as a lease at inception of the arrangement. The Company recognizes a ROU asset and a lease liability at the lease commencement date. ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the related lease. Finance leases are under the current and non-current liabilities and the underlying assets are included in property and equipment on the consolidated balance sheet. For operating and finance leases, the lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. As most of the Company’s leases do not provide an implicit rate of return, on a quarterly basis, the Company’s incremental borrowing rate is used, together with the lease term information available at commencement date of the lease, in determining the present value of lease payments. Operating lease liabilities include the noncancellable period of the lease plus related options to extend or terminate lease terms that are reasonably certain of being exercised. Lease payments included in the measurement of the lease liability comprise fixed payments owed over the lease term. Leases with an initial term of 12 months or less (“short term leases”) are not recorded on the balance sheet; and the lease expense on short-term leases is recognized on a straight-line basis over the lease term. The Company entered into a sublease for its former headquarters, which is being accounted for under lessor accounting. The nature of the sublease did not relieve the Company of its obligations under the original lease. The lease for the prior headquarters was an operating lease and, as such, the Company continues to account for the original lease as it did prior to entering the sublease. Since the former facility is not a component of the Company’s central operations, the income from the sublease and the expenses under the original lease are recorded in Other income, net on our Consolidated Statement of Operations.
Convertible Notes Payable and Liability Classified Contract Consideration Convertible Notes Payable	Convertible Notes Payable and Liability Classified Contract Consideration Convertible Notes Payable The Company accounted for the Convertible Notes Payable at amortized cost pursuant to Financial Accounting Standards Board (“FASB”) ASC Topic 470, Debt. The Company accounted for the Contract Consideration Convertible Notes Payable issued as consideration related to a related party contract (see Note 9, “Debt and Convertible Notes Payable”), as liability classified convertible instruments in accordance with FASB ASC 718, “Stock Compensation” (“ASC 718”). Under ASC 718, liability classified convertible instruments are measured at fair value at the grant date and at each reporting date (see Note 10, “Fair Value Measurements”) with the change in fair value included in the consolidated statements of operations.
Fair Value Measurements	Fair Value Measurements The Company categorizes financial assets and liabilities using a three-tier fair value hierarchy, based on the nature of the inputs used to determine fair value. Inputs refer broadly to assumptions that market participants would use to value an asset or liability and may be observable or unobservable. When determining the fair value of assets and liabilities, the Company uses the most reliable measurement available. See Note 10, “Fair Value Measurements.” Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. •Level 1 — Quoted prices in active markets for identical assets or liabilities; •Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and •Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when it satisfies performance obligations under the terms of the contract with a customer, and control of the promised goods are transferred to the customer or services are performed, in an amount that reflects the consideration the Company expects to be entitled in exchange for those goods or services. The Company recognizes revenue based on a five-step model when all of the following criteria have been met: (i) a contract with a customer exists, (ii) performance obligations have been identified, (iii) the price to the customer has been determined, (iv) the price to the customer has been allocated to the performance obligations, and (v) performance obligations are satisfied. Products and services are sold with fixed or determinable prices. Variable consideration is estimated for the Contract Shortfall Fees from the ProFrac Agreement (see Note 16, “Related Party Transactions”) using the most likely amount and the Company includes an estimated amount of variable consideration in the transaction price only if it is probable that a subsequent change in the estimate of the amount of variable consideration would not result in a significant revenue reversal. A significant revenue reversal would occur if a subsequent change in the estimate of the variable consideration would result in a significant downward adjustment to the amount of cumulative revenue recognized from that contract when the change in estimate occurs. Certain sales include right of return provisions, which are considered when recognizing revenue and deferred accordingly, and discounts are offered to customers for prompt payment. The Company does not act as an agent in any of its revenue arrangements. In recognizing revenue for products and services, the Company determines the transaction price of contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services can be distinguished in the context of the contract. The timing of revenue recognition, billings and cash collections results in billed and unbilled accounts receivable included in accounts receivable, net and accounts receivable, related party on our Consolidated Balance Sheet. The majority of the CT segment revenue is chemical products that are sold at a point in time based on when control transfers to the customer determined by agreed upon delivery terms. Contracts with customers for the sale of products generally state the terms of the sale, including the quantity and price of each product purchased. Additionally, the CT segment offers various services associated to products sold, which includes field services, installation, maintenance, and other functions. These services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation when the Company has a right to invoice the customer. The DA segment recognizes revenue for sales of equipment at the time of sale based on when control transfers to the customer based on agreed upon delivery terms. Additionally, the Company offers various services associated with products sold, which includes field services, installation, maintenance, and other functions. Services are recognized upon completion of commissioning and installation due to the short-term nature of the performance obligation. There may be additional performance obligations related to providing ongoing or reoccurring maintenance. Revenue for these types of arrangements is recognized ratably over time throughout the contract period. Additionally, the Company may provide subscription-type arrangements with customers in which monthly reoccurring revenue is recognized ratably over time in accordance with agreed upon terms and conditions. Customers may be invoiced for such maintenance and subscription-type arrangements, and revenue not yet recognizable is reported under accrued liabilities and deferred revenue on the consolidated balance sheets. Payment terms for both the CT and DA segments are customarily 30-60 days for domestic products or services and 60-90 days for international products and services from invoice receipt. Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Contract assets associated with incomplete performance obligations are not material. The Company applies several practical expedients including: •Sales commissions are expensed as selling, general and administrative expenses when incurred because the amortization period is generally one year or less. •The Company’s payment terms are short-term in nature with settlements of one year or less. As a result, the Company does not adjust the promised amount of consideration for the effects of a significant financing component. •In most service contracts, the Company has the right to consideration from a customer in an amount that corresponds directly with the value to the customer of the Company’s performance obligations completed to date and as such the Company recognizes revenue in the amount to which it has a right to invoice. •The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer. Such taxes are included in accrued liabilities on our consolidated balance sheet until remitted to the governmental agency. Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for as a fulfillment cost and are included in cost of sales in our consolidated statement of operations.
Foreign Currency Translation	Foreign Currency Translation The Company’s functional currency is primarily the U.S. dollar. The Company operates principally in the United States and substantially all assets and liabilities of the Company are denominated in U.S. dollars. Financial statements of foreign subsidiaries that are not U.S. dollar functional currency are prepared using the currency of the primary economic environment of the foreign subsidiaries as the functional currency. Assets and liabilities of those foreign subsidiaries are translated into U.S. dollars at exchange rates in effect as of the end of identified reporting periods. Revenue and expense transactions are translated using the average monthly exchange rate for the reporting period. Resultant translation adjustments are recognized as other comprehensive income (loss) within stockholders’ equity.
Comprehensive Income	Comprehensive Income Comprehensive income encompasses all changes in stockholders’ equity, except those arising from investments and distributions to stockholders. The Company’s comprehensive income loss includes consolidated net income (loss) and foreign currency translation adjustments.
Research and Development Costs	Research and Development Costs Expenditures for research activities relating to product development and improvement are charged to expense as incurred.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for temporary differences between financial statement carrying amounts and the tax bases of assets and liabilities and are measured using the tax rates expected to be in effect when the differences reverse. Deferred tax assets are also recognized for operating loss and tax credit carry forwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company’s policy is to record interest and penalties related to uncertain tax positions as income tax expense.
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation expense, related to stock options, restricted stock awards and restricted stock units, is recognized based on their grant-date fair values. The Company recognizes compensation expense, net of estimated forfeitures, on a straight-line basis over the requisite service period of the award. Estimated forfeitures are based on historical experience.
Stock Warrants	Stock Warrants The Company evaluated the Pre-Funded Warrants issued in February 2023 (the “February 2023 Warrants”) (see Note 13, “Stockholders’ Equity) in accordance with ASC 815-40, “Contracts in Entity’s Own Equity” and determined the February 2023 Warrants meet the criteria to be classified within stockholders’ equity. Accordingly, the Company reclassified the balance of the Initial ProFrac Agreement Contract Consideration Convertible Notes Payable (see Note 9, “Debt and Convertible Notes Payable”) upon conversion for the February 2023 Warrants within additional paid in capital.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant items subject to estimates and assumptions include estimated variable consideration included in contract transaction price; the useful lives of property and equipment; long lived asset impairment assessments; stock-based compensation expense; allowance for credit losses for accounts receivable; valuation allowances for inventories and deferred tax assets; recoverability and timing of the realization of contract assets; and, in 2023, the fair value of liability classified Contract Consideration Convertible Notes Payable.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Changes to U.S. GAAP are established by the FASB. We evaluate the applicability and impact of all authoritative guidance issued by the FASB. Guidance not listed below was assessed and determined to be either not applicable, clarifications of items listed below, immaterial or already adopted by the Company. New Accounting Standards Issued and Not Adopted as of March 31, 2024 The FASB issued ASU No. 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”). The amendments under ASU 2023-09 were created as a response to requests from investors, lenders, creditors and other parties to enhance transparency and effectiveness of tax disclosures to help them better assess how an entity’s operations and related tax risks affect an entity’s tax rate and potential future cash flows. ASU 2023-09 requires that entities annually disclose the amount of taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions and that those amounts are also disaggregated by individual jurisdictions equal to or greater than 5% of total income taxes paid (net of funds received). ASU 2023-09 adds a requirement that entities disaggregate income (loss) from continuing operations before income tax expense (benefit) between domestic and foreign. The amendments also require entities to disaggregate income tax expense (benefit) by federal, state and foreign jurisdictions. The amendments under ASU 2023-09 also remove certain prior requirements. Public business entities are no longer required to disclose the nature and estimate of change in the unrecognized tax benefits balance in the next 12 months or make a statement that an estimate cannot be determined. In addition public business entities are no longer required to disclose the cumulative amount of each type of temporary difference for which a deferred tax liability has not been recognized due to the exception to recognizing deferred taxes related to subsidiaries and corporate joint ventures. ASU 2023-09 goes into effect for annual periods beginning after December 15, 2024 and early adoption is permitted for annual financial statements not yet issued or made available for issuance. Adoption of the ASU is on a prospective basis, with the option to apply retrospectively. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures. The FASB issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures.” This standard improves reportable segment disclosure requirements through enhanced disclosures around significant segment expenses. The amendments under this standard require interim and annual disclosures of significant segment expenses regularly provided to the chief operating decision maker (“CODM”). In addition, public entities are required to disclose the amount of “other segment items” by segment and their composition; make annual disclosures about a reportable segment’s profit/loss and assets; and clarify if the CODM uses more than one measure of a segment’s profit or loss in assessing performance and resource allocation and disclose the name and title of the CODM. This ASU is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and the amendments are applied retrospectively to all prior periods presented. The Company is currently evaluating the impact of the adoption of the ASU on the related disclosures.
Earnings (Loss) Per Share	Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period, which includes the February 2023 Warrants (See Note 9, “Debt and Convertible Notes Payable”, and Note 13, “Stockholders’ Equity”). Diluted earnings (loss) per common share is calculated by dividing the adjusted net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive common share equivalents consist of incremental shares of common stock issuable upon conversion of convertible notes payable, exercise of stock warrants and vesting and settlement of stock awards. The dilutive effect of non-vested stock issued under share‑based compensation plans, shares issuable under the Employee Stock Purchase Plan (ESPP), employee stock options outstanding, and the Pre-Funded stock warrants are computed using the treasury stock method. The dilutive effect of the Convertible Notes is computed using the if‑converted method.
Segment Information	Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the chief operating decision-maker in deciding how to allocate resources and assess performance. The operations of the Company are categorized into the following reportable segments: Chemistry Technologies. The CT segment includes green specialty chemistries, logistics and technology services, which enable its customers to pursue improved efficiencies and performance throughout the life cycle of their wells, and also helping customers improve their ESG and operational goals. Customers of the CT segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. Data Analytics. The DA segment includes the design, development, production, sale and support of equipment and services that create and provide valuable information on the composition and properties of energy customers’ hydrocarbon fluids. The company markets products and services that support in-line data analysis of hydrocarbon components and properties. Customers of the DA segment span across the entire oil and gas market, from upstream production to midstream facilities to refineries and distribution networks. Performance is based upon a variety of criteria. The primary financial measure is segment operating income (loss). Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segments.

v3.24.1.u1

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Property and Equipment	Depreciation or amortization of property and equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows: Buildings and leasehold improvements 2-30 years Machinery and equipment 7-10 years Furniture and fixtures 3 years Land improvements 20 years Transportation equipment 2-5 years Computer equipment and software 3-7 years Property and equipment are as follows (in thousands): March 31, 2024 December 31, 2023 Land $ 886  $ 886  Land improvements 520  520  Buildings and leasehold improvements 5,487  5,483  Machinery and equipment 7,065  6,993  Furniture and fixtures 520  520  Transportation equipment 945  945  Computer equipment and software 1,772  1,696     Property and equipment 17,195  17,043  Less accumulated depreciation (12,134) (11,914) Property and equipment, net $ 5,061  $ 5,129
Schedule of Allowance for Doubtful Accounts for Continuing Operations	Changes in the allowance for credit losses are as follows (in thousands):   March 31, 2024 December 31, 2023 Balance, beginning of year $ 745  $ 623  Charges to provision for credit losses, net of recoveries 32  138  Write-offs (405) (16) Balance, end of period $ 372  $ 745

v3.24.1.u1

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total revenue disaggregated by revenue source is as follows (in thousands):   Three months ended March 31,   2024 2023 Revenue: Products (1) $ 39,106  $ 46,767  Services 1,268  1,240  $ 40,374  $ 48,007  (1) Product revenue includes sales to related parties as described in Note 16, “Related Party Transactions.” Disaggregation of Cost of Sales The Company differentiates cost of sales based on whether the cost is attributable to tangible goods sold, cost of services sold or other costs which cannot be directly attributable to either tangible goods or services. Total cost of sales disaggregated is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Tangible goods sold $ 27,025  $ 41,529  Services 94  141  Other 4,434  4,457  $ 31,553  $ 46,127  Other cost of sales represent costs directly associated with the generation of revenue but which cannot be attributed directly to tangible goods sold or services. Examples of other costs of sales are certain personnel costs and equipment rental and insurance costs. Cost of sales split between external and related party sales is as follows (in thousands):   Three months ended March 31,   2024 2023 Cost of sales: Cost of sales for external customers $ 12,952  $ 11,196  Cost of sales for related parties 18,601  34,931  $ 31,553  $ 46,127

v3.24.1.u1

Contract Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue Recognition [Abstract]
Schedule of Outstanding Contract Assets	Contract assets are as follows (in thousands): March 31, 2024 December 31, 2023 Contract assets $ 83,060  $ 83,060  Less accumulated amortization (9,672) (8,405) Contract assets, net 73,388  74,655  Less current contract assets (7,019) (5,836) Contract assets, long term $ 66,369  $ 68,820  The below table reflects our estimated amortization per year (in thousands) based on the Company’s current forecasted revenues from the ProFrac Agreement. Years ending December 31, Amortization 2024 (excluding the three months ended March 31, 2024) $ 5,029  2025 8,749  2026 9,538  2027 9,538  2028 9,538  Thereafter through May 2032 30,996  Total contract assets $ 73,388

v3.24.1.u1

Inventories (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Components of Inventory	Inventories are as follows (in thousands): March 31, 2024 December 31, 2023 Raw materials $ 5,618  $ 5,299  Finished goods 14,281  13,660  Inventories 19,899  18,959  Less reserve for excess and obsolete inventory (6,028) (6,121) Inventories, net $ 13,871  $ 12,838

v3.24.1.u1

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Depreciation or amortization of property and equipment, including operating lease right-of-use assets (“ROU”), is calculated using the straight-line method over the shorter of the lease term or the asset’s estimated useful life as follows: Buildings and leasehold improvements 2-30 years Machinery and equipment 7-10 years Furniture and fixtures 3 years Land improvements 20 years Transportation equipment 2-5 years Computer equipment and software 3-7 years Property and equipment are as follows (in thousands): March 31, 2024 December 31, 2023 Land $ 886  $ 886  Land improvements 520  520  Buildings and leasehold improvements 5,487  5,483  Machinery and equipment 7,065  6,993  Furniture and fixtures 520  520  Transportation equipment 945  945  Computer equipment and software 1,772  1,696     Property and equipment 17,195  17,043  Less accumulated depreciation (12,134) (11,914) Property and equipment, net $ 5,061  $ 5,129

v3.24.1.u1

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Expense and Supplemental Cash Flow Information	The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2024 2023 Operating lease expense $ 784  $ 869  Finance lease expense: Amortization of assets 4  4  Interest on lease liabilities —  1  Total finance lease expense 4  5  Short-term lease expense 259  41  Total lease expense $ 1,047  $ 915  Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 1,654  $ 1,365  Operating cash flows from finance leases 13  10  Financing cash flows from finance leases —  1
Schedule of Maturities of Operating Leases Liabilities	Maturities of lease liabilities as of March 31, 2024 are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2024 (excluding the three months ended March 31, 2024) $ 2,073  $ 13  2025 2,046  —  2026 1,732  —  2027 1,660  —  2028 1,518  —  Thereafter 2,815  —  Total lease payments $ 11,844  $ 13  Less: Interest (2,640) —  Present value of lease liabilities $ 9,204  $ 13
Schedule of Maturities of Finance Leases Liabilities	Maturities of lease liabilities as of March 31, 2024 are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2024 (excluding the three months ended March 31, 2024) $ 2,073  $ 13  2025 2,046  —  2026 1,732  —  2027 1,660  —  2028 1,518  —  Thereafter 2,815  —  Total lease payments $ 11,844  $ 13  Less: Interest (2,640) —  Present value of lease liabilities $ 9,204  $ 13
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2024 December 31, 2023 Operating Leases Operating lease right-of-use assets $ 4,336  $ 5,030  Current portion of operating lease liabilities 2,083  2,449  Long-term operating lease liabilities 7,121  7,676  Total operating lease liabilities $ 9,204  $ 10,125  Finance Leases Property and equipment $ 147  $ 147  Accumulated depreciation (74) (70) Property and equipment, net $ 73  $ 77  Current portion of finance lease liabilities $ 13  $ 22  Long-term finance lease liabilities —  —  Total finance lease liabilities $ 13  $ 22  Weighted Average Remaining Lease Term Operating leases 5.6 years 5.5 years Finance leases 0.3 years 0.6 years Weighted Average Discount Rate Operating leases 9.4  % 9.5  % Finance leases 8.5  % 8.5  %
Schedule of Future Sublease Rental Income	Sublease Income On April 1, 2023, the Company entered into an agreement to sublease its office and lab space in Houston, Texas beginning September 1, 2023 and continuing until October 30, 2030. The rental income from the sublease is included in the Company’s statement of operations in Other income (expense), net, and offsets the monthly rental expense of $86 thousand from the Company’s lease of the facility from the landlord. Sublease rental income for future years are as follows (in thousands): Years ending December 31, Rental Income 2024 (excluding the three months ended March 31, 2024) $ 575  2025 767  2026 767  2027 767  2028 767  Thereafter 1,406  Total rental income $ 5,049

v3.24.1.u1

Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Current Accrued Liabilities	Current accrued liabilities are as follows (in thousands):   March 31, 2024 December 31, 2023 Severance costs $ 417  $ 648  Payroll and benefits 937  2,138  Legal costs 201  37  Contingent liability for earn-out provision 30  56  Deferred revenue, current 303  550  Taxes other than income taxes 182  656  Other 1,295  1,805  Total current accrued liabilities $ 3,365  $ 5,890

v3.24.1.u1

Debt and Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	Long-term debt, including current portion, is as follows (in thousands): March 31, 2024 December 31, 2023 Flotek PPP loan $ 194  $ 239  Less current maturities (179) (179) Total long-term debt, net of current portion $ 15  $ 60
Schedule of Loan Repayments	Loan repayments are scheduled as follows (in thousands): Years ending December 31, Repayment 2024 (excluding the three months ended March 31, 2024) $ 134  2025 60  Total Flotek PPP loan $ 194

v3.24.1.u1

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements, Recurring	The following table presents the Company’s liabilities that are measured at fair value on a recurring basis and the level within the fair value hierarchy (in thousands): March 31, December 31, Level 1 Level 2 Level 3 2024 Level 1 Level 2 Level 3 2023 Contingent earnout consideration $ —  $ —  $ 30  $ 30  $ —  $ —  $ 56  $ 56  Total $ —  $ —  $ 30  $ 30  $ —  $ —  $ 56  $ 56
Schedule of Valuation Techniques	March 31, 2024 December 31, 2023 Risk-free interest rate 4.97  % 4.58  % Expected volatility 70.0  % 70.0  % Term until liquidation (years) 1.13  1.38  Stock price (pre-Reverse Stock Split basis) $ 3.74  $ 3.92  Discount rate 13.67  % 11.86  %
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table presents the changes in balances of liabilities for the three months ended March 31, 2024 and 2023 classified as Level 3 (in thousands): Three months ended March 31, 2024 2023 Balance - beginning of period $ 56  $ 84,153  Increase in principal of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest —  85  Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest —  1,331  Change in fair value of contingent earnout consideration (26) (358) Change in fair value of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable —  786  Change in fair value of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable —  (26,881) Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity —  (15,092) Balance - end of period $ 30  $ 44,024

v3.24.1.u1

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	The income tax provision (benefit) differed from the amounts computed by applying the U.S. federal income tax rate of 21% to income (loss) before income tax for the reasons set forth below: Three months ended March 31, 2024 2023 U.S. federal statutory tax rate 21.0  % 21.0  % State income taxes, net of federal benefit 13.5  —  Non-U.S. income taxed at different rates (5.2) 0.1  Increase (reduction) in tax benefit related to stock-based awards 1.2  0.4  Change in valuation allowance (18.8) (20.5) Permanent differences related to CARES Act —  (1.1) Non-deductible expenses 1.8  0.1  Effective income tax rate 13.5  % —  %

v3.24.1.u1

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted	For all periods presented in the table below, weighted average shares and earnings (loss) per share reflect the effects of the Reverse Stock Split. The calculation of the basic and diluted earnings (loss) per share for the three months ended March 31, 2024 and 2023 is as follows (in thousands):   Three months ended March 31,   2024 2023 Numerator: Net income for basic earnings per share $ 1,562  $ 21,343  Adjustments to net income available to shareholders Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable —  1,571  Valuation gain on Contract Consideration Convertible Notes Payable carried at fair value —  (26,095) Adjusted net income (loss) for diluted earnings per share $ 1,562  $ (3,181) Denominator: Basic weighted average shares outstanding 29,431  16,468  Dilutive effect of convertible notes payable —  9,994  Dilutive effect of warrants outstanding 779  —  Dilutive effect of stock options and restricted shares 106  —  Diluted weighted average shares outstanding 30,316  26,462  Basic earnings per share $ 0.05  $ 1.30  Diluted earnings (loss) per share $ 0.05  $ (0.12) Anti-dilutive incremental shares excluded from denominator for diluted earnings computation Average number of diluted shares for June 2022 stock warrants (1) —  1,500  Average number of diluted shares for options and restricted stock (1) —  170  (1) These items were not included in the dilution calculation for the three months ended March 31, 2023 due to their anti-dilutive effect as it would reduce the loss per share.

v3.24.1.u1

Supplemental Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	Supplemental cash flow information is as follows (in thousands):            Three months ended March 31,   2024 2023 Supplemental cash flow information: Interest paid $ 210  $ 18  Supplemental non cash financing and investing activities: Conversion of convertible notes payable to common stock —  8,996  Conversion of convertible notes payable to February 2023 Warrants —  11,040  Conversion of Initial Contract Consideration Convertible Notes Payable to February 2023 Warrants —  15,092

v3.24.1.u1

Business Segment, Geographic and Major Customer Information (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Schedule of Financial Information Regarding Reportable Segments	Summarized financial information of the reportable segments is as follows (in thousands): As of and for the three months ended March 31, Chemistry Technologies Data Analytics Corporate and Other Total 2024 Revenue from external customers Products $ 11,159  $ 933  $ —  $ 12,092  Services 526  562  —  1,088  Total revenue from external customers 11,685  1,495  —  13,180  Revenue from related party Products 27,014  —  —  27,014  Services —  180  —  180  Total revenue from related parties 27,014  180  —  27,194  Gross profit 8,401  420  —  8,821  Income (loss) from operations 6,106  (424) (3,574) 2,108  Depreciation 159  35  26  220  Interest on ABL —  —  181  181  Other interest —  —  97  97  Income tax —  —  242  242  Additions to long-lived assets 147  —  5  152  2023 Revenue from external customers Products $ 8,561  $ 1,941  $ —  $ 10,502  Services 664  486  —  1,150  Total revenue from external customers 9,225  2,427  —  11,652  Revenue from related party Products 36,265  —  —  36,265  Services —  90  90  Total revenue from related parties 36,265  90  —  36,355  Gross profit 434  1,446  —  1,880  Change in fair value of Contract Consideration Convertible Notes Payable (26,095) —  —  (26,095) Income (loss) from operations 23,379  457  (5,325) 18,511  Paid-in-kind interest on Contract Consideration Convertible Notes Payable 1,416  —  —  1,416  Paid-in-kind interest on convertible notes payable —  —  155  155  Depreciation 157  18  1  176  Income tax —  —  9  9  Additions to long-lived assets 30  95  32  157  Assets of the Company by reportable segments are as follows (in thousands): March 31, 2024 December 31, 2023 Chemistry Technologies $ 139,551  $ 138,559  Data Analytics 6,253  6,604  Corporate and Other 10,046  12,350  Total assets $ 155,850  $ 157,513
Schedule of Revenue by Geographic Location	Revenue by geographic location is as follows (in thousands):   Three months ended March 31,   2024 2023 U.S. (1) $ 39,259  $ 46,126  UAE 741  1,403  Other countries 374  478  Total revenue $ 40,374  $ 48,007  (1) Includes revenue from related party
Schedule of Revenue by Major Customers	Revenue from major customers, as a percentage of consolidated revenue, is as follows (in thousands): Revenue % of Total Revenue Three months ended March 31, 2024 Customer A (Related Party) $ 27,194  67.4  % Three months ended March 31, 2023 Customer A (Related Party) $ 36,355  75.7  %
Schedule of Expenditure With Major Suppliers by Reporting Segments	Expenditure with major suppliers, as a percentage of consolidated supplier expenditure, is as follows (in thousands): Three months ended March 31, Expenditure % of Total Expenditure 2024 Supplier A $ 7,747  29.7  % Supplier B 5,020  19.2  % 2023 Supplier A $ 16,954  40.1  % Supplier B 7,145  16.9  % Supplier C 4,504  10.6  %

v3.24.1.u1

Organization and Nature of Operations (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Organization and Nature of Operations
Number of operation segments (segments) | segment	2
Gross profit	$ 8,821	$ 1,880
Net income	1,562	$ 21,343
Related Party
Organization and Nature of Operations
Accounts receivable	38,655		$ 34,569
Contract Service Fee
Organization and Nature of Operations
Amounts of transaction			$ 20,100
Contract Service Fee | Related Party
Organization and Nature of Operations
Amounts of transaction	8,700
Accounts receivable	13,700
Contract Service Fee | Related Party | Payment One
Organization and Nature of Operations
Accounts receivable	5,000
Contract Service Fee | Related Party | Payment Two
Organization and Nature of Operations
Accounts receivable	$ 8,700

v3.24.1.u1

Summary of Significant Accounting Policies - Restricted Cash (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Restricted cash	$ 100	$ 102

v3.24.1.u1

Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Accounts Receivable, Allowance for Credit Loss
Balance, beginning of year	$ 745	$ 623	$ 623
Charges to provision for credit losses, net of recoveries	32	$ 23	138
Write-offs	(405)		(16)
Balance, end of period	$ 372		$ 745

v3.24.1.u1

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended
	Mar. 31, 2024
ProFrac Agreement
Debt Instrument
Amortization period	10 years

v3.24.1.u1

Summary of Significant Accounting Policies - Property and Equipment (Details)	Mar. 31, 2024
Buildings and leasehold improvements | Maximum
Property, Plant and Equipment
Property, Plant and equipment, useful life	30 years
Buildings and leasehold improvements | Minimum
Property, Plant and Equipment
Property, Plant and equipment, useful life	2 years
Machinery and equipment | Maximum
Property, Plant and Equipment
Property, Plant and equipment, useful life	10 years
Machinery and equipment | Minimum
Property, Plant and Equipment
Property, Plant and equipment, useful life	7 years
Furniture and fixtures
Property, Plant and Equipment
Property, Plant and equipment, useful life	3 years
Land improvements
Property, Plant and Equipment
Property, Plant and equipment, useful life	20 years
Transportation equipment | Maximum
Property, Plant and Equipment
Property, Plant and equipment, useful life	5 years
Transportation equipment | Minimum
Property, Plant and Equipment
Property, Plant and equipment, useful life	2 years
Computer equipment and software | Maximum
Property, Plant and Equipment
Property, Plant and equipment, useful life	7 years
Computer equipment and software | Minimum
Property, Plant and Equipment
Property, Plant and equipment, useful life	3 years

v3.24.1.u1

Summary of Significant Accounting Policies - Revenue Recognition (Details)	Mar. 31, 2024
Data Analytics | Minimum
Segment Reporting Information
Payment period (in days)	30 days
Data Analytics | Minimum | International
Segment Reporting Information
Payment period (in days)	90 days
Data Analytics | Maximum
Segment Reporting Information
Payment period (in days)	60 days
Chemistry Technologies Segment | Minimum
Segment Reporting Information
Payment period (in days)	30 days
Chemistry Technologies Segment | Minimum | International
Segment Reporting Information
Payment period (in days)	90 days
Chemistry Technologies Segment | Maximum
Segment Reporting Information
Payment period (in days)	60 days

v3.24.1.u1

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue
Total revenues	$ 40,374	$ 48,007
Product
Disaggregation of Revenue
Total revenues	39,106	46,767
Services
Disaggregation of Revenue
Total revenues	$ 1,268	$ 1,240

v3.24.1.u1

Revenue from Contracts with Customers - Cost of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue
Cost of sales	$ 31,553	$ 46,127
Nonrelated Party
Disaggregation of Revenue
Cost of sales	12,952	11,196
Related Party | ProFrac Holdings
Disaggregation of Revenue
Cost of sales	18,601	34,931
Tangible goods sold
Disaggregation of Revenue
Cost of sales	27,025	41,529
Services
Disaggregation of Revenue
Cost of sales	94	141
Other
Disaggregation of Revenue
Cost of sales	$ 4,434	$ 4,457

v3.24.1.u1

Contract Assets - Contract Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Contract Asset
Contract assets	$ 83,060	$ 83,060
Less accumulated amortization	(9,672)	(8,405)
Total contract assets	73,388	74,655
Less current contract assets	(7,019)	(5,836)
Long-term contract assets	$ 66,369	$ 68,820

v3.24.1.u1

Contract Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	May 17, 2022	Feb. 02, 2022
Disaggregation of Revenue
Contract assets	$ 83,060		$ 83,060
Capitalized contract fees	3,600
Long-term contract assets	66,369		$ 68,820
Amortization of contract into revenue	$ 1,300	$ 1,300
ProFrac Agreement
Disaggregation of Revenue
Contract assets				$ 69,500	$ 10,000

v3.24.1.u1

Contract Assets - Estimated Amortization (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Revenue Recognition [Abstract]
2024 (excluding the three months ended March 31, 2024)	$ 5,029
2025	8,749
2026	9,538
2027	9,538
2028	9,538
Thereafter through May 2032	30,996
Total contract assets	$ 73,388	$ 74,655

v3.24.1.u1

Inventories - Components of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 5,618	$ 5,299
Finished goods	14,281	13,660
Inventories	19,899	18,959
Less reserve for excess and obsolete inventory	(6,028)	(6,121)
Inventories, net	$ 13,871	$ 12,838

v3.24.1.u1

Inventories - Narratives (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Chemistry Technologies Segment
Inventory
Provision for excess and obsolete inventory	$ 300	$ 100
Data Analytics
Inventory
Provision for excess and obsolete inventory	$ 13	$ 100

v3.24.1.u1

Property and Equipment - Components of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Components of Property, Plant and Equipment
Property and equipment	$ 17,195	$ 17,043
Less accumulated depreciation	(12,134)	(11,914)
Property and equipment, net	5,061	5,129
Land
Components of Property, Plant and Equipment
Property and equipment	886	886
Land improvements
Components of Property, Plant and Equipment
Property and equipment	520	520
Buildings and leasehold improvements
Components of Property, Plant and Equipment
Property and equipment	5,487	5,483
Machinery and equipment
Components of Property, Plant and Equipment
Property and equipment	7,065	6,993
Furniture and fixtures
Components of Property, Plant and Equipment
Property and equipment	520	520
Transportation equipment
Components of Property, Plant and Equipment
Property and equipment	945	945
Computer equipment and software
Components of Property, Plant and Equipment
Property and equipment	$ 1,772	$ 1,696

v3.24.1.u1

Property and Equipment - Narratives (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 220	$ 176

v3.24.1.u1

Leases - Components of Lease Expense and Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating lease expense	$ 784	$ 869
Finance lease expense:
Amortization of assets	4	4
Interest on lease liabilities	0	1
Total finance lease expense	4	5
Short-term lease expense	259	41
Total lease expense	1,047	915
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	1,654	1,365
Operating cash flows from finance leases	13	10
Financing cash flows from finance leases	$ 0	$ 1

v3.24.1.u1

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Operating Leases
2024 (excluding the three months ended March 31, 2024)	$ 2,073
2025	2,046
2026	1,732
2027	1,660
2028	1,518
Thereafter	2,815
Total lease payments	11,844
Less: Interest	(2,640)
Present value of lease liabilities	9,204	$ 10,125
Finance Leases
2024 (excluding the three months ended March 31, 2024)	13
2025	0
2026	0
2027	0
2028	0
Thereafter	0
Total lease payments	13
Less: Interest	0
Present value of lease liabilities	$ 13	$ 22

v3.24.1.u1

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Operating Leases
Operating lease right-of-use assets	$ 4,336	$ 5,030
Current portion of operating lease liabilities	2,083	2,449
Long-term operating lease liabilities	7,121	7,676
Total operating lease liabilities	9,204	10,125
Finance Leases
Property and equipment	147	147
Accumulated depreciation	(74)	(70)
Property and equipment, net	73	77
Current portion of finance lease liabilities	13	22
Long-term finance lease liabilities	0	0
Total finance lease liabilities	$ 13	$ 22
Weighted Average Remaining Lease Term
Operating leases (in years)	5 years 7 months 6 days	5 years 6 months
Finance leases (in years)	3 months 18 days	7 months 6 days
Weighted Average Discount Rate
Operating leases (in percentage)	9.40%	9.50%
Finance leases (in percentage)	8.50%	8.50%

v3.24.1.u1

Leases -Future Sublease Rental Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Leases [Abstract]
Monthly rental expense	$ 86
2024 (excluding the three months ended March 31, 2024)		$ 575
2025		767
2026		767
2027		767
2028		767
Thereafter		1,406
Total rental income		$ 5,049

v3.24.1.u1

Accrued Liabilities - Schedule of Current Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accrued liabilities, current
Severance costs	$ 417	$ 648
Payroll and benefits	937	2,138
Legal costs	201	37
Contingent liability for earn-out provision	30	56
Deferred revenue, current	303	550
Taxes other than income taxes	182	656
Other	1,295	1,805
Total current accrued liabilities	$ 3,365	$ 5,890

v3.24.1.u1

Debt and Convertible Notes Payable - Narratives (Details)							1 Months Ended	3 Months Ended
	Sep. 06, 2023 shares	Aug. 14, 2023 USD ($)	May 17, 2023 USD ($) $ / shares shares	Feb. 02, 2023 USD ($) $ / shares shares	Jan. 05, 2023 USD ($)	Feb. 02, 2022 USD ($) day $ / shares	Apr. 30, 2020 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Jan. 04, 2023 USD ($)	May 17, 2022 USD ($)
Debt Instrument
Asset-based loan								$ 3,111,000		$ 7,492,000
Interest on ABL								181,000
Other income								0	$ 4,522,000
ProFrac Holdings | February 2023 Warrants | Related Party
Debt Instrument
Conversion of notes to common stock (in shares) | shares				12,683,281
Line of Credit | Asset Based Loan
Debt Instrument
Debt instrument term (years)		24 months
Initial credit availability		$ 13,800,000
Percentage of eligible accounts receivable (percent)		85.00%
Percentage value of eligible inventory (percent)		60.00%
Asset-based loan								3,100,000
Available borrowing capacity								6,000,000
Interest on ABL								200,000
Unamortized issuance cost								$ 100,000
Debt instrument stated interest rate (percent)		5.50%						11.00%
Commitment fee percentage (percent)		1.00%
Debt instrument, non usage fee (percent)		0.25%
Debt instrument, termination fee contingency period		12 months
Line of credit facility covenant amount minimum tangible net worth								$ 11,000,000
Line of Credit | Asset Based Loan | Period One
Debt Instrument
Early termination fee (percent)		2.50%
Line of Credit | Asset Based Loan | Period Two
Debt Instrument
Early termination fee (percent)		1.50%
Line of Credit | Asset Based Loan | Prime Rate
Debt Instrument
Basis spread on variable rate (percent)		2.50%
Line of Credit | Asset Based Loan | Maximum
Debt Instrument
Percentage of eligible accounts receivable (percent)		100.00%
Unsecured Debt | Flotek PPP loan
Debt Instrument
Proceeds from debt							$ 4,800,000
Forgiveness of debt					$ 4,400,000
Principal amount								194,000		$ 239,000	$ 4,800,000
Accrued interest forgiveness					100,000
Aggregate principal amount					$ 400,000
Repaid in monthly installments								15,000
Other income								4,500,000
Gain (loss) on extinguishment of debt, principal								4,400,000
Gain (loss) on extinguishment of debt, accrued interest								$ 100,000
Convertible Debt | February 2023 Warrants
Debt Instrument
Conversion price (in dollar per share) | $ / shares				$ 0.0001
Convertible Debt | PIPE Transaction
Debt Instrument
Debt instrument term (years)						1 year
Debt instrument stated interest rate (percent)						10.00%
Aggregate principal amount						$ 21,200,000
Proceeds from convertible notes						$ 20,100,000
Conversion price (in dollar per share) | $ / shares						$ 1.088125
Stock price trigger (in dollars per share) | $ / shares				0.8705		2.50
Stock price trigger for trading period (in dollars per share) | $ / shares						$ 1.741
Threshold trading days | day						20
Consecutive trading days | day						30
Convertible Debt | ProFrac Agreement Contract
Debt Instrument
Debt instrument stated interest rate (percent)						10.00%
Aggregate principal amount						$ 10,000,000
Conversion price (in dollar per share) | $ / shares				$ 1.19
Convertible debt, fair value disclosures				$ 15,100,000
Convertible Debt | ProFrac Agreement Contract | Related Party
Debt Instrument
Conversion of notes to common stock (in shares) | shares	12,683,281
Convertible notes payable				11,000,000
Paid-in-kind interest expense				1,000,000
Convertible debt, fair value disclosures				$ 15,100,000
Convertible Debt | ProFrac Agreement Contract | Related Party | Reverse Stock Split
Debt Instrument
Conversion of notes to common stock (in shares) | shares	2,113,881
Convertible Debt | ProFrac Agreement Contract | Estimate of Fair Value Measurement
Debt Instrument
Convertible debt, fair value disclosures						$ 10,000,000
Convertible Debt | Amended ProFrac Agreement
Debt Instrument
Debt instrument stated interest rate (percent)												10.00%
Aggregate principal amount												$ 50,000,000
Conversion price (in dollar per share) | $ / shares			$ 0.64
Convertible debt, fair value disclosures			$ 40,600,000
Convertible Debt | Amended ProFrac Agreement | Reverse Stock Split
Debt Instrument
Conversion of notes to common stock (in shares) | shares			10,582,821
Convertible Debt | Amended ProFrac Agreement | Related Party
Debt Instrument
Conversion price (in dollar per share) | $ / shares			$ 0.8705
Conversion of notes to common stock (in shares) | shares	12,683,280		63,496,922	12,683,280
Convertible notes payable				$ 11,000,000
Paid-in-kind interest expense				$ 1,000,000
Convertible debt, fair value disclosures			$ 40,600,000
Convertible Debt | Amended ProFrac Agreement | Related Party | Reverse Stock Split
Debt Instrument
Conversion of notes to common stock (in shares) | shares	2,113,880
Convertible Debt | Amended ProFrac Agreement | Estimate of Fair Value Measurement
Debt Instrument
Convertible debt, fair value disclosures												$ 69,500,000
Convertible Notes Payable | Other Convertible Debt
Debt Instrument
Conversion of notes to common stock (in shares) | shares				10,335,840
Convertible notes payable				$ 9,000,000
Paid-in-kind interest expense				$ 800,000
Convertible Notes Payable | Other Convertible Debt | Reverse Stock Split
Debt Instrument
Conversion of notes to common stock (in shares) | shares				1,722,640

v3.24.1.u1

Debt and Convertible Notes Payable - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Jan. 04, 2023
Debt Instrument
Less current maturities	$ (179)	$ (179)
Unsecured Debt | Flotek PPP loan
Debt Instrument
Flotek PPP loan	194	239	$ 4,800
Total long-term debt, net of current portion	$ 15	$ 60

v3.24.1.u1

Debt and Convertible Notes Payable - Schedule of Loan Repayments (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Repayment
2024 (excluding the three months ended March 31, 2024)	$ 134
2025	60
Total Flotek PPP loan	$ 194

v3.24.1.u1

Fair Value Measurements - Recurring (Details) - Recurring - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring
Contingent earnout consideration	$ 30	$ 56
Liabilities measured at fair value on a recurring basis	30	56
Level 1
Fair Value, Assets and Liabilities Measured on Recurring
Contingent earnout consideration	0	0
Liabilities measured at fair value on a recurring basis	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring
Contingent earnout consideration	0	0
Liabilities measured at fair value on a recurring basis	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring
Contingent earnout consideration	30	56
Liabilities measured at fair value on a recurring basis	$ 30	$ 56

v3.24.1.u1

Fair Value Measurements - Monte Carlo Simulation (Details)	Mar. 31, 2024	Dec. 31, 2023
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques
Earn out provision, measurement input	0.0497	0.0458
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques
Earn out provision, measurement input	0.700	0.700
Term until liquidation (years)
Fair Value Measurement Inputs and Valuation Techniques
Earn out provision, measurement input	1.13	1.38
Stock price (pre-Reverse Stock Split basis)
Fair Value Measurement Inputs and Valuation Techniques
Earn out provision, measurement input	3.74	3.92
Discount rate
Fair Value Measurement Inputs and Valuation Techniques
Earn out provision, measurement input	0.1367	0.1186

v3.24.1.u1

Fair Value Measurements - Narratives (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2023	May 17, 2023	Feb. 02, 2023	May 17, 2022	Feb. 02, 2022
ProFrac Agreement Contract | Convertible Debt
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures			$ 15,100
Conversion price (in dollar per share)			$ 1.19
Change in fair value	$ 786
ProFrac Agreement Contract | Convertible Debt | Related Party
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures			$ 15,100
ProFrac Agreement Contract | Estimate of Fair Value Measurement | Convertible Debt
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures					$ 10,000
Amended ProFrac Agreement | Convertible Debt
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures		$ 40,600
Conversion price (in dollar per share)		$ 0.64
Amended ProFrac Agreement | Convertible Debt | Related Party
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures		$ 40,600
Conversion price (in dollar per share)		$ 0.8705
Amended ProFrac Agreement | Estimate of Fair Value Measurement | Convertible Debt
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures				$ 69,500
Convertible notes payable	$ 26,900
Recurring | Level 3
Assets Measured at Fair Value on a Nonrecurring Basis
Convertible debt, fair value disclosures					$ 10,000

v3.24.1.u1

Fair Value Measurements - Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Balance - beginning of period	$ 56	$ 84,153
Balance - end of period	30	44,024
ProFrac Agreement Contract | Convertible Debt
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Change in fair value		786
ProFrac Agreement
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest	0	85
Conversion of Initial ProFrac Agreement Contract Consideration Convertible Notes Payable on maturity	0	(15,092)
Amended ProFrac Agreement
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Increase in principal of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable for paid-in-kind interest	0	1,331
Change in fair value	$ 0	$ (26,881)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Debt Instrument, Realized Gain (Loss) On Fair Value Adjustment, Before Tax	Debt Instrument, Realized Gain (Loss) On Fair Value Adjustment, Before Tax
Change in fair value of contingent earnout consideration
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Change in fair value	$ (26)	$ (358)
Contingent Portion Of Convertible Debt
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Change in fair value	$ 0

v3.24.1.u1

Income Taxes - Reconciliation of Effective Tax Rate (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
U.S. federal statutory tax rate	21.00%	21.00%
State income taxes, net of federal benefit	13.50%	0.00%
Non-U.S. income taxed at different rates	(5.20%)	0.10%
Increase (reduction) in tax benefit related to stock-based awards	1.20%	0.40%
Change in valuation allowance	(18.80%)	(20.50%)
Permanent differences related to CARES Act	0.00%	(1.10%)
Non-deductible expenses	1.80%	0.10%
Effective income tax rate	13.50%	0.00%

v3.24.1.u1

Income Taxes - Narrative (Details) $ in Millions	Mar. 31, 2024 USD ($)
Operating Loss Carryforwards
Operating loss carryforwards	$ 194.8
Deferred tax assets, operating loss carryforwards, subject to expiration	$ 46.4
Percentage of net operating loss carryforward that can offset net income	100.00%
Deferred tax assets, operating loss carryforwards, not subject to expiration	$ 148.4
Percentage of indefinite lived carryforward that can offset taxable in come per year	80.00%
Operating loss carryforward, interest limitation carryforward related to section 163	$ 0.7
Tax credit carryforward	3.8
Operating loss carryforward estimated limitation on use	3.5
Operating loss carryforwards, maximum uplift, amount	24.5
Tax credit valuation allowance, due to expiration	3.8
State and Local Jurisdiction
Operating Loss Carryforwards
Operating loss carryforwards	96.1
Operating loss valuation allowance, due to expiration	$ 31.3

v3.24.1.u1

Stockholders’ Equity - Narrative (Details) $ / shares in Units, $ in Millions	Sep. 25, 2023 shares	Sep. 14, 2023	Sep. 06, 2023 shares	May 17, 2023 USD ($) $ / shares shares	Feb. 02, 2023 USD ($) $ / shares shares	Jun. 21, 2022 USD ($) $ / shares shares	Feb. 02, 2022 $ / shares
Common and Preferred Stock
Reverse stock split ratio		0.1667
Reverse stock splits (shares)	30,772,837
Reverse Stock Split
Common and Preferred Stock
Conversion of stock, shares converted (in shares)	184,438,695
Related Party | ProFrac Holdings | February 2023 Warrants
Common and Preferred Stock
Conversion of notes to common stock (in shares)					12,683,281
Affiliated Entity | ProFrac Services, LLC | June 2022 Warrants
Common and Preferred Stock
Exercise price of warrants or rights (in dollars per share) | $ / shares						$ 0.0001
Exchanged value of warrants | $						$ 19.5
Number of securities called by warrants or rights (in shares)						13,104,839
Warrant exercise fee | $						$ 4.5
Proceeds from related party debt | $						4.5
Other receivables | $						$ 4.5
Affiliated Entity | ProFrac Services, LLC | June 2022 Warrants | Reverse Stock Split
Common and Preferred Stock
Number of securities called by warrants or rights (in shares)						2,184,140
Convertible Debt | February 2023 Warrants
Common and Preferred Stock
Conversion price (in dollar per share) | $ / shares					$ 0.0001
Amended ProFrac Agreement | Convertible Debt
Common and Preferred Stock
Exercise price of warrants or rights (in dollars per share) | $ / shares					$ 0.0001
Convertible debt, fair value disclosures | $				$ 40.6
Conversion price (in dollar per share) | $ / shares				$ 0.64
Amended ProFrac Agreement | Convertible Debt | Reverse Stock Split
Common and Preferred Stock
Conversion of notes to common stock (in shares)				10,582,821
Amended ProFrac Agreement | Convertible Debt | Related Party
Common and Preferred Stock
Reverse stock splits (shares)				10,582,821
Conversion of notes to common stock (in shares)			12,683,280	63,496,922	12,683,280
Convertible notes payable | $					$ 11.0
Paid-in-kind interest expense | $					$ 1.0
Convertible debt, fair value disclosures | $				$ 40.6
Conversion price (in dollar per share) | $ / shares				$ 0.8705
Amended ProFrac Agreement | Convertible Debt | Related Party | Reverse Stock Split
Common and Preferred Stock
Reverse stock splits (shares)				10,582,821
Conversion of notes to common stock (in shares)			2,113,880
Other Convertible Debt | Convertible Notes Payable
Common and Preferred Stock
Conversion of notes to common stock (in shares)					10,335,840
Convertible notes payable | $					$ 9.0
Paid-in-kind interest expense | $					$ 0.8
Other Convertible Debt | Convertible Notes Payable | Reverse Stock Split
Common and Preferred Stock
Conversion of notes to common stock (in shares)					1,722,640
PIPE Transaction | Convertible Debt
Common and Preferred Stock
Reverse stock splits (shares)					1,722,640
Stock price trigger (in dollars per share) | $ / shares					$ 0.8705		$ 2.50
Conversion price (in dollar per share) | $ / shares							$ 1.088125
ProFrac Agreement Contract | Convertible Debt
Common and Preferred Stock
Convertible debt, fair value disclosures | $					$ 15.1
Conversion price (in dollar per share) | $ / shares					$ 1.19
ProFrac Agreement Contract | Convertible Debt | Related Party
Common and Preferred Stock
Conversion of notes to common stock (in shares)			12,683,281
Convertible notes payable | $					$ 11.0
Paid-in-kind interest expense | $					1.0
Convertible debt, fair value disclosures | $					$ 15.1
ProFrac Agreement Contract | Convertible Debt | Related Party | Reverse Stock Split
Common and Preferred Stock
Conversion of notes to common stock (in shares)			2,113,881

v3.24.1.u1

Earnings (Loss) Per Share - Schedule of Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net income for basic earnings per share	$ 1,562	$ 21,343
Adjustments to net income available to shareholders
Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable	0	1,571
Adjusted net income (loss) for diluted earnings per share	$ 1,562	$ (3,181)
Denominator:
Basic weighted average shares outstanding (in shares)	29,431	16,468
Dilutive effect of convertible notes payable (in shares)	0	9,994
Dilutive effect of warrants outstanding (in shares)	779	0
Dilutive effect of stock options and restricted shares (in shares)	106	0
Diluted weighted average shares outstanding (in shares)	30,316	26,462
Basic earnings per share (in dollars per share)	$ 0.05	$ 1.30
Diluted earnings (loss) per share (in dollars per share)	$ 0.05	$ (0.12)
Convertible Notes Payable
Adjustments to net income available to shareholders
Paid-in-Kind interest expense on convertible notes payable and Contract Consideration Convertible Notes Payable	$ 0	$ 1,571
Valuation gain on Contract Consideration Convertible Notes Payable carried at fair value	$ 0	$ (26,095)
Stock Warrants
Denominator:
Anti-dilutive incremental shares excluded from denominator for diluted earnings computation	0	1,500
Options and Restricted
Denominator:
Anti-dilutive incremental shares excluded from denominator for diluted earnings computation	0	170

v3.24.1.u1

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental cash flow information:
Interest paid	$ 210	$ 18
Supplemental non cash financing and investing activities:
Conversion of Initial Contract Consideration Convertible Notes Payable to February 2023 Warrants	0	15,092
Common Stock
Supplemental non cash financing and investing activities:
Conversion of convertible notes payable to common stock	0	8,996
Stock Warrants
Supplemental non cash financing and investing activities:
Conversion of convertible notes payable to common stock	$ 0	$ 11,040

v3.24.1.u1

Related Party Transactions (Details)						3 Months Ended		12 Months Ended
	Sep. 25, 2023 shares	Sep. 06, 2023 shares	May 17, 2023 USD ($) $ / shares shares	Feb. 02, 2023 USD ($) fleet $ / shares shares	May 17, 2022 USD ($) fleet	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Feb. 02, 2022 USD ($)
Related Party Transaction
Reverse stock splits (shares) | shares	30,772,837
Revenue from external customers						$ 40,374,000	$ 48,007,000
Amortization of contract into revenue						1,300,000	1,300,000
Cost of sales						31,553,000	46,127,000
Contract Service Fee
Related Party Transaction
Amounts of transaction								$ 20,100,000
Contract Service Fee Collected
Related Party Transaction
Amounts of transaction						15,100,000
Related Party
Related Party Transaction
Revenue from external customers						27,194,000	36,355,000
Amortization of contract into revenue						1,300,000	1,300,000
Accounts receivable						38,655,000		$ 34,569,000
Related Party | Contract Service Fee
Related Party Transaction
Amounts of transaction						8,700,000
Accounts receivable						13,700,000
Related Party | ProFrac Agreement Contract
Related Party Transaction
Increase in number of active hydraulic fleets | fleet				30
Convertible Debt | February 2023 Warrants
Related Party Transaction
Conversion price (in dollar per share) | $ / shares				$ 0.0001
Convertible Debt | ProFrac Agreement Contract
Related Party Transaction
Debt instrument, face amount									$ 10,000,000
Convertible debt, fair value disclosures				$ 15,100,000
Conversion price (in dollar per share) | $ / shares				$ 1.19
Convertible Debt | Amended ProFrac Agreement
Related Party Transaction
Debt instrument, face amount					$ 50,000,000
Convertible debt, fair value disclosures			$ 40,600,000
Conversion price (in dollar per share) | $ / shares			$ 0.64
Convertible Debt | Amended ProFrac Agreement | Reverse Stock Split
Related Party Transaction
Conversion of notes to common stock (in shares) | shares			10,582,821
Convertible Debt | Related Party | ProFrac Agreement Contract
Related Party Transaction
Convertible notes payable				$ 11,000,000
Paid-in-kind interest expense				1,000,000
Conversion of notes to common stock (in shares) | shares		12,683,281
Convertible debt, fair value disclosures				15,100,000
Convertible Debt | Related Party | ProFrac Agreement Contract | Reverse Stock Split
Related Party Transaction
Conversion of notes to common stock (in shares) | shares		2,113,881
Convertible Debt | Related Party | Amended ProFrac Agreement
Related Party Transaction
Convertible notes payable				11,000,000
Paid-in-kind interest expense				$ 1,000,000
Conversion of notes to common stock (in shares) | shares		12,683,280	63,496,922	12,683,280
Convertible debt, fair value disclosures			$ 40,600,000
Conversion price (in dollar per share) | $ / shares			$ 0.8705
Reverse stock splits (shares) | shares			10,582,821
Convertible Debt | Related Party | Amended ProFrac Agreement | Reverse Stock Split
Related Party Transaction
Conversion of notes to common stock (in shares) | shares		2,113,880
Reverse stock splits (shares) | shares			10,582,821
PIPE Transaction | Convertible Debt | Related Party
Related Party Transaction
Debt instrument, face amount									$ 10,000,000
Fleet purchase commitment percentage									33.00%
Conditional revenue shortfall rate (percent)									25.00%
Amended ProFrac Agreement | Convertible Debt | Related Party
Related Party Transaction
Debt instrument, face amount					$ 50,000,000
Fleet purchase commitment percentage					70.00%
Increase in number of active hydraulic fleets | fleet					30
Potential increase to contract term (years)					10 years
ProFrac Holdings | Related Party
Related Party Transaction
Cost of sales						18,601,000	34,931,000
ProFrac Holdings | Related Party | February 2023 Warrants
Related Party Transaction
Conversion of notes to common stock (in shares) | shares				12,683,281
ProFrac Services, LLC | Related Party
Related Party Transaction
Revenue from external customers						$ 27,200,000	$ 36,400,000

v3.24.1.u1

Business Segment, Geographic and Major Customer Information - Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Summarized financial information regarding reportable segments
Revenue from external customers	$ 40,374	$ 48,007
Gross profit	8,821	1,880
Change in fair value of Contract Consideration Convertible Notes Payable		(26,095)
Income (loss) from operations	2,108	18,511
Paid-in-kind interest on Contract Consideration Convertible Notes Payable		1,416
Paid-in-kind interest on convertible notes payable		155
Depreciation	220	176
Interest on ABL	181
Other interest	97
Income tax	242	9
Additions to long-lived assets	152	157
Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	13,180	11,652
Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	27,194	36,355
Product
Summarized financial information regarding reportable segments
Revenue from external customers	39,106	46,767
Product | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	12,092	10,502
Product | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	27,014	36,265
Services
Summarized financial information regarding reportable segments
Revenue from external customers	1,268	1,240
Services | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	1,088	1,150
Services | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	180	90
Operating Segments | Chemistry Technologies Segment
Summarized financial information regarding reportable segments
Gross profit	8,401	434
Change in fair value of Contract Consideration Convertible Notes Payable		(26,095)
Income (loss) from operations	6,106	23,379
Paid-in-kind interest on Contract Consideration Convertible Notes Payable		1,416
Paid-in-kind interest on convertible notes payable		0
Depreciation	159	157
Interest on ABL	0
Other interest	0
Income tax	0	0
Additions to long-lived assets	147	30
Operating Segments | Chemistry Technologies Segment | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	11,685	9,225
Operating Segments | Chemistry Technologies Segment | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	27,014	36,265
Operating Segments | Chemistry Technologies Segment | Product | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	11,159	8,561
Operating Segments | Chemistry Technologies Segment | Product | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	27,014	36,265
Operating Segments | Chemistry Technologies Segment | Services | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	526	664
Operating Segments | Chemistry Technologies Segment | Services | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Operating Segments | Data Analytics
Summarized financial information regarding reportable segments
Gross profit	420	1,446
Change in fair value of Contract Consideration Convertible Notes Payable		0
Income (loss) from operations	(424)	457
Paid-in-kind interest on Contract Consideration Convertible Notes Payable		0
Paid-in-kind interest on convertible notes payable		0
Depreciation	35	18
Interest on ABL	0
Other interest	0
Income tax	0	0
Additions to long-lived assets	0	95
Operating Segments | Data Analytics | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	1,495	2,427
Operating Segments | Data Analytics | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	180	90
Operating Segments | Data Analytics | Product | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	933	1,941
Operating Segments | Data Analytics | Product | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Operating Segments | Data Analytics | Services | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	562	486
Operating Segments | Data Analytics | Services | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	180	90
Corporate and Other
Summarized financial information regarding reportable segments
Gross profit	0	0
Change in fair value of Contract Consideration Convertible Notes Payable		0
Income (loss) from operations	(3,574)	(5,325)
Paid-in-kind interest on Contract Consideration Convertible Notes Payable		0
Paid-in-kind interest on convertible notes payable		155
Depreciation	26	1
Interest on ABL	181
Other interest	97
Income tax	242	9
Additions to long-lived assets	5	32
Corporate and Other | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Corporate and Other | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Corporate and Other | Product | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Corporate and Other | Product | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Corporate and Other | Services | Nonrelated Party
Summarized financial information regarding reportable segments
Revenue from external customers	0	0
Corporate and Other | Services | Related Party
Summarized financial information regarding reportable segments
Revenue from external customers	$ 0

v3.24.1.u1

Business Segment, Geographic and Major Customer Information - Assets by Reportable Segments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Segment Reporting Information
Total assets	$ 155,850	$ 157,513
Operating Segments | Chemistry Technologies
Segment Reporting Information
Total assets	139,551	138,559
Operating Segments | Data Analytics
Segment Reporting Information
Total assets	6,253	6,604
Corporate and Other
Segment Reporting Information
Total assets	$ 10,046	$ 12,350

v3.24.1.u1

Business Segment, Geographic and Major Customer Information - Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues from External Customers and Long-Lived Assets
Revenue from external customers	$ 40,374	$ 48,007
U.S.
Revenues from External Customers and Long-Lived Assets
Revenue from external customers	39,259	46,126
UAE
Revenues from External Customers and Long-Lived Assets
Revenue from external customers	741	1,403
Other countries
Revenues from External Customers and Long-Lived Assets
Revenue from external customers	$ 374	$ 478

v3.24.1.u1

Business Segment, Geographic and Major Customer Information - Major Customers (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information
Revenue from external customers	$ 40,374	$ 48,007
Related Party
Segment Reporting Information
Revenue from external customers	27,194	36,355
Customer Concentration Risk | Sales | Customer A (Related Party) | Related Party
Segment Reporting Information
Revenue from external customers	$ 27,194	$ 36,355
Percentage of revenue by major customers (in percentage)	67.40%	75.70%

v3.24.1.u1

Business Segment, Geographic and Major Customer Information - Major Suppliers (Details) - Purchases - Cost of Goods and Service - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplier A
Segment Reporting Information
Supplies expense	$ 7,747	$ 16,954
Total spend (in percentage)	29.70%	40.10%
Supplier B
Segment Reporting Information
Supplies expense	$ 5,020	$ 7,145
Total spend (in percentage)	19.20%	16.90%
Supplier C
Segment Reporting Information
Supplies expense		$ 4,504
Total spend (in percentage)		10.60%

---